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ABSTRACT
Artificial Intelligence (AI) has impacted our lives in many meaningful ways. For our
research, we focus on improving disease diagnosis systems by analyzing medical images using
AI, specifically deep learning technologies. The recent advances in deep learning technologies
are leading to enhanced performance for medical image analysis and computer-aided disease
diagnosis. In this dissertation, we explore a major research area in medical image analysis -
Image classification. Image classification is the process to assign an image a label from a fixed
set of categories. For our research, we focus on the problem of Alzheimer’s Disease (AD)
diagnosis from 3D structural Magnetic Resonance Imaging (sMRI) and Positron Emission
Tomography (PET) brain scans.
Alzheimer’s Disease is a severe neurological disorder. In this dissertation, we address
challenges related to Alzheimer’s Disease diagnosis and propose several models for improved
diagnosis. We focus on analyzing the 3D Structural MRI (sMRI) and Positron Emission
Tomography (PET) brain scans to identify the current stage of Alzheimer’s Disease: Nor-
mal Controls (CN), Mild Cognitive Impairment (MCI), and Alzheimer’s Disease (AD). This
dissertation demonstrates ways to improve the performance of a Convolutional Neural Net-
work (CNN) for Alzheimer’s Disease diagnosis. Besides, we present approaches to solve the
class-imbalance problem and improving classification performance with limited training data
for medical image analysis. To understand the decision of the CNN, we present methods to
visualize the behavior of a CNN model for disease diagnosis. As a case study, we analyzed
brain PET scans of AD and CN patients to see how CNN discriminates among data samples
of different classes.
Additionally, this dissertation proposes a novel approach to generate synthetic medical
images using Generative Adversarial Networks (GANs). Working with the limited dataset
and small amount of annotated samples makes it difficult to develop a robust automated
disease diagnosis model. Our proposed model can solve such issue and generate brain MRI
and PET images for three different stages of Alzheimer’s Disease - Normal Control (CN),
Mild Cognitive Impairment (MCI), and Alzheimer’s Disease (AD). Our proposed approach
can be generalized to create synthetic data for other medical image analysis problems and
help to develop better disease diagnosis model.
INDEX WORDS: Medical Imaging, Deep Learning, Alzheimer’s Disease, MRI, PET,
Brain Imaging, Synthetic Data Generation, Visualization, Convolu-
tional Neural Network, Generative Adversarial Networks, Computer-
aided-diagnosis
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1Chapter 1
INTRODUCTION
In this chapter, we present the general introduction to this thesis intended to allow a
quick appraisal of its contents, contributions, supporting publications and structure.
1.1 AI-Assisted Disease Diagnosis
Artificial Intelligence (AI) has made substantial progress in recent days. AI is the area of
computer science that aims to mimic human cognitive functions and emphasize the creation
of intelligent machines. Today AI assisted models are performing incredible tasks with high
accuracy at a massive scale. AI has enabled us to build tools that can learn from experience,
adjust to new inputs and complete tasks with expert human-level performance. In this thesis,
we aim to use AI for solving various problems in the field of medical image analysis focusing
on improving performance for disease diagnosis.
Computer-aided diagnosis (CAD) refers to systems that provide information about dis-
ease assessment by interpreting medical images. AI can improve the performance of CAD
systems with discoveries and judgments leading to faster and more accurate diagnosis. AI
can handle a vast amount of information faster than any human with more accurate analysis.
Besides, AI can improve the accuracy by learning itself and acquiring expertise comparable
to specialists.
1.2 Medical Image Analysis
Medical image analysis focuses on extracting insights from images of biological tissue
with computational analysis. Medical Imaging creates visual representations of body inte-
rior for clinical assessment and uses several imaging techniques such as Computer Tomogra-
phy (CT), Magnetic Resonance Imaging (MRI), Ultrasound, Radiography(X-Ray), Positron
2emission tomography (PET) etc. The scope of medical image analysis ranges from clinical
studies of medical imaging and disease in patients to neuroscience studies that target to find
scientific information such as human brain structure and functionality. Several computa-
tional methods such as signal processing, machine learning, biophysics etc. are used to built
applications for medical image analysis. In recent days deep learning techniques are helping
to identify, classify and qualify patterns in medical images with the advantages of learning
hierarchical feature representations directly from data instead of using hand-crafted features.
1.3 Classification in Medical Imaging
Image classification aims to assign an image to categories or classes of interest by ana-
lyzing its contents. In computer-aided diagnosis, image classification plays a significant role.
Classification in medical imaging refers to the task of analyzing an input image data and
assign it an output class indicating the presence of a disease or not. For example, classifying
patients as having Alzheimer’s Disease based on 3D brain MRI data.
1.3.1 Alzheimer’s Disease Diagnosis
Alzheimer’s Disease (AD) is the most prevailing type of dementia. The prevalence of
AD is estimated to be around 5% after 65 years old and is staggering 30% for more than
85 years old in developed countries. It is estimated that by 2050, around 0.64 Billion peo-
ple will be diagnosed with AD [4]. Alzheimer’s Disease destroys brain cells causing people
to lose their memory, mental functions and ability to continue daily activities. Initially,
Alzheimer’s Disease affects the part of the brain that controls language and memory. As a
result, AD patients suffer from memory loss, confusion, and difficulty in speaking, reading
or writing. They often forget about their life and may not recognize their family members.
They struggle to perform daily activities such as brushing hair or combing tooth. All these
make AD patients anxious or aggressive or to wander away from home. Ultimately, AD de-
stroys the part of the brain controlling breathing and heart functionality which lead to death.
3There are three major stages in Alzheimer’s Disease - very mild, mild and moderate.
Detection of Alzheimer’s Disease (AD) is still not accurate until a patient reaches mod-
erate AD stage. For proper medical assessment of AD, several things are needed such as
physical and neurobiological exams, Mini-Mental State Examination (MMSE), and patient’s
detailed history. As AD is incurable, earlier diagnosis of AD can help for proper treatment.
For our research, we consider the automated diagnosis of Alzheimer’s Disease in 3D struc-
tural MRI brain scans and Positron Emission Tomography (PET) brain scans. We conduct
experiments using OASIS dataset and Alzheimer’s Disease Neuroimaging Initiative (ADNI)
dataset for classification of the Alzheimer’s Disease (AD), Mild Cognitive Impairment (MCI)
and CN (normal/healthy controls) to evaluate the proposed model. Mild Cognitive Impair-
ment (MCI) combines the very mild and mild stages of Alzheimer’s disease. Fig. 1.1 shows
some brain MRI images with different AD stages. As the disease progresses, Abnormal pro-
(a)
(b)
(c)
Figure (1.1) Sample Brain MRI Images from ADNI Database Presenting Different Stages
of Alzheimer’s Disease. (a) Normal/healthy controls (CN); (b) Mild Cognitive Impair-
ment(MCI); (c) Alzheimers Disease (AD).
4teins (amyloid-β [Aβ] and hyperphosphorylated tau) are accumulated in the brain of an AD
patient. This abnormal protein accumulation leads to progressive synaptic, neuronal and
axonal damage. The changes in the brain due to AD have a stereotypical pattern of early
medial temporal lobe (entorhinal cortex and hippocampus) involvement, followed by pro-
gressive neocortical damage [5]. Such changes occur years before the AD symptoms appear.
It looks like the toxic effects of hyperphosphorylated tau and/or amyloid-β [Aβ] gradually
erodes the brain, and when a clinical threshold is surpassed, amnestic symptoms start to
develop. Structural MRI (sMRI) and Positron Emission Tomography (PET) can be used
for measuring these progressive changes in the brain due to the AD. Our research work fo-
cuses on analyzing sMRI and PET data using deep learning model for Alzheimer’s Disease
diagnosis.
1.4 Feature Learning
Feature learning or representation learning refers to a set of methods that allows a model
to automatically identify the representations needed for feature detection or classification
from raw data. Feature learning aims to find an appropriate representation of data to
perform a machine learning task, eliminates the need to manual feature engineering and
allows a machine to learn the features themselves. Real world data - images and video
are complex and highly variable. For intelligent machines, it is necessary that they can
discover useful features or representations from the raw data themselves. Traditional hand-
crafted feature generation is expensive regarding time, cost and requires expert knowledge
and human labor. Moreover, they do not generalize well. Efficient feature learning techniques
can solve these issues and automate and generalize the learning process. Feature learning
algorithms have two categories: supervised and unsupervised feature learning. In Supervised
feature learning, the algorithm learns the feature from a labelled training dataset. On the
other hand, in unsupervised feature learning, features are learned from unlabeled input data.
51.5 Deep Learning
Deep Learning is an area of Artificial Intelligence, specifically a part of Machine Learning
Algorithms. Recently, deep learning models have been famous for their ability to learn fea-
ture representations from the input data. Deep learning networks use a layered, hierarchical
structure to learn increasingly abstract feature representations from the data. Deep learn-
ing architectures learn simple, low-level features from the data and build complex high-level
features in a hierarchy fashion. Deep learning technologies have demonstrated revolutionary
performance in several areas, e.g., visual object recognition, human action recognition, nat-
ural language processing, object tracking, image restoration, denoising, segmentation tasks,
audio classification, brain-computer interaction, etc. Nowadays deep learning techniques are
being successfully applied for medical image analysis.
1.6 Objective
We developed computer-aided diagnosis models using deep learning technologies. We
explored a significant area in medical image analysis - classification. For classification task as
a case study, we developed automated models for Alzheimer’s disease diagnosis using brain
MRI and PET data. We worked for solving the class-imbalance problem in medical data and
developing efficient diagnosis models with limited training data. We propose solution to solve
limited dataset problem by generating synthetic medical images. We present approaches to
understand the decision of convolutional neural network to discriminate among samples of
different disease class.
1.7 Motivation
AI can offer several advantages over traditional analytics, and clinical decision-making
approaches. The health-care industry is a high priority sector where people expect the
highest level of service. Proper diagnosis of disease is crucial to treatment and saving a
patient’s life. For example, Alzheimer’s disease is not curable. But if we can diagnosis it at
6an early stage, physicians can at least try to delay the harmful impact of the disease. On
the other hand, diagnosis is expensive and requires specialized expertise. In many countries
of the world, primary medical care is limited, and expert physicians are not available in time
of need. If we can build computer-aided-diagnosis systems that can automatically analyze
medical images and diagnosis disease with human-level expertise, it will reduce the cost of
treatment dramatically. Early diagnosis of disease will save the lives of millions of people
and bring exciting break-throughs in patient care.
While several research works have been done for analyzing natural images such as object
classification, recognition, tracking, segmentation etc., research in medical image analysis is
still limited. To mitigate the gap, we choose to focus on medical image analysis for developing
better disease diagnosis systems.
1.8 Challenges
For our research, we plan to use deep learning technologies for medical image analysis.
There are several challenges related to working with medical data. First, medical images
are generally private and having access to those data is challenging and often impossible.
Second, for natural image analysis such as object classification, millions of data are available
to train an automated classifier. On the other hand, in disease classification, typically
few hundreds data sample are available. Third, it requires specialized expertise to capture
and annotate the ground truth data for the learning process. Often availability of those
experts is limited. Fourth, the dataset is often imbalanced. When we develop an automated
disease diagnosis model, we require enough sample data from both the positive and negative
class. In medical image analysis, typically more than 90% data belongs to the positive class.
Additionally, there are heterogeneous image data available due to different image capturing
protocol. Several pre-processing steps are necessary so that the algorithm can work with
varying types of data.
Deep Learning models learn automatically from the input data without requiring any
hand-crafted feature generation. Convolutional Neural Network (CNN) is the deep learning
7model that has achieved tremendous success in image analysis task. In our research work,
we are going to use CNN for developing the automated diagnosis model. CNN requires a
vast training dataset for efficient training. But in medical image analysis, such large dataset
is not available. Designing an efficient classifier that can work with limited training data is
a significant challenge in medical image analysis.
Analyzing medical images requires significant expertise. As we are working for
Alzheimer’s Disease Diagnosis, we have seen that there is a similarity in the normal healthy
brain data of older people and the Alzheimer’s Disease data. It is very challenging to dif-
ferentiate between both. Diagnosing AD at an early stage is even more challenging, and
extensive knowledge and experience are required.
1.9 Contribution
The current thesis presents a multidisciplinary research efforts to investigate the emerg-
ing deep learning technologies for medical image analysis. We have developed several models
for Alzheimer’s disease diagnosis using deep learning technologies that outperform previous
state-of-the-art. We have presented preprocessing approaches for better analysis of MRI
data. We have demonstrated approaches that can solve the class-imbalance problem in
medical image analysis. We have experimented and introduced several ways to improve
the performance of a CNN classifier for disease diagnosis with limited training data. We
proposed solution to solve limited dataset problem by generating synthetic medical images
and presented approaches to understand the decision of convolutional neural network to
discriminate among samples of different disease class.
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1.11 Thesis Outline
The remainder of this thesis is organized as follows. Chapter 2 presents background
study related to deep learning and medical image analysis. Chapter 3 reviews existing
approaches to Alzheimer’s Disease Diagnosis and Lung segmentation. Chapter 4, 5, and 6
present our proposed approaches for Alzheimer’s Disease diagnosis. Chapter 7 presents our
proposed approach to generate synthetic medical images. Chapter 8 describes our method
for understanding behavior of 3D Convolutional Neural Network for Alzheimer’s Disease and
Mild Cognitive Impairment diagnosis. Finally, Chapter 9 presents the directions for future
work and Chapter 10 concludes the dissertation.
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Chapter 2
BACKGROUND STUDY
In this chapter, we discuss an overview of some background ideas of the ensuing sections
of this thesis. To set the stage, we review feature learning algorithms and neural network
models. Next, we discuss in detail about Convolutional Neural Network (CNN) which is
the underlying architecture of the proposed diagnosis frameworks of this thesis. We briefly
describe Generative Adversarial Networks that were used to generate synthetic medical im-
ages. Finally, we present the theory behind Magnetic Resonance Imaging (MRI), Structural
MRI (sMRI) analysis, Positron Emission Tomography (PET), and PET analysis.
Artificial Intelligence (AI) is an area of computer science that focuses on the creation
of intelligent machines. AI algorithms simulate intelligent behaviour in computers that
can work and behave like a human. Machine Learning is a group of AI techniques that
use statistical methods to enable machines to learn with data, without being explicitly
programmed and improve with experiences. Deep Learning is a subset of machine learning
as shown in Figure 2.1. Deep Learning models solve problems by using neural networks ( a
series of algorithms modelled after the human brain).
2.1 Learning Algorithms
Machine Learning models are divided into two broad categories - supervised and unsu-
pervised algorithms. In supervised learning, there is input data (X) and output variable (Y)
and the algorithm learns the mapping function from input to output.
f : X → Y ; (2.1)
Y typically represents an instance from a fixed set of class. The target of the learning
algorithm is to approximate the mapping function well so that when a new input data
12
Figure (2.1) Relation Among AI, Machine Learning, and Deep Learning.
comes, the model can predict the output class for it. For example, an algorithm trained on
the labelled dataset of benign or malignant tumours learns to identify patients with cancer
or not.
On the contrary, unsupervised algorithms learn to process data without any label and
can identify patterns without any guidance. For example, clustering algorithms can discover
the inherent groupings in the data, such as grouping customers by purchasing behaviour.
Figure (2.2) Block Diagram of a Neural Network.
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2.2 Neural Network
Neural networks or Artificial neural networks are a set of learning algorithms that
replicate the way humans learn. They consist of connected neurons or learning units with
some activation function a and parameters Θ = {ω, β}, where ω is a set of weights and β
is a set of biases. Neural networks are organized in layers consisted of neurons. Input data
is passed to the network via the ‘input layer’, which communicates to one or more ‘hidden
layers’ where the actual processing is done. The hidden layers transform the input and then
link to an ’output layer’ that produces the output. Figure 2.2 shows block diagram of a basic
neural network. The activation function is a linear combination of the input to the neurons
and the parameters:
a = σ(ωTx+ b) (2.2)
Deep learning methods often use neural networks with lots of hidden layers and are
often referred to as deep neural networks.
2.3 Convolutional Neural Network
Convolutional neural network (CNN) is a feed-forward artificial neural network and
the most popular deep learning model. Artificial neural networks are systems of connected
neurons that exchange messages with each other. The connections have respective weights
that can be tuned based on experience. As a result, neural networks become adaptive to
inputs and capable of learning. Since regular neural networks have fully connected neurons,
so they do not scale well to full images. If an image is of size 28x28x3, a single fully connected
neuron in the first hidden layer will have 28*28*3 = 2352 weights. Now if the image is of
size 512x512x3, the weight would be 512*512*3 = 786,432 for a single neuron. Now it is very
much expected that the full network will have a lot of neurons. As a result, the parameters
will add up quickly too. So not only the full connectivity would be wasteful, but also the
high number of parameters would lead to overfitting.
CNN is a feed-forward network which means information only moves forward from input
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nodes to the output nodes via the hidden nodes (if any). CNN assumes that inputs are images
and thus encodes specific properties to the architecture. As a result, the forward function
becomes more efficient, and the amount of parameters in the network reduces vastly too.
In a convolutional neural network, the neurons are arranged in three dimensions - weight,
height, and depth. So if the input image has size 28x28x3, then the input volume would have
dimension 28x28x3. A small region of the layer would be connected to the neurons of the
next layer. They won’t be connected fully to all neurons in the next layer. The input image
would be reduced to a single vector of class scores by the final output layer. The vector would
be arranged along the depth dimension. Each layer converts the 3D input volume to a 3D
output volume of neuron activations. The depth of the layer is equal to the number of color
channels in the image. Width and heights are determined by the dimension of the image.
Each layer of a CNN uses a differentiable function to convert one volume of activations to
Figure (2.3) Illustration of a Convolutional Neural Network.
another. There are three main types of layers - Convolutional Layer, Pooling Layer, and
Fully-Connected Layer. These layers are stacked to form a full CNN architecture. The
neurons connected to the local regions of the input computes a dot product of their weights
and the respective area. Convolutional layer computes the output of these neurons. Pooling
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layer performs a downsampling operation along the spatial dimensions - width and height.
The fully connected layer where each neuron is connected to all the numbers of the previous
volume computes the output class score. Thus, an input image is converted to a final class
score by layer by layer transformation of the original pixels. The convolutional and fully
connected layer has parameters such as weights and biases of neurons. The transformation of
these layers is a function of the activations of the input volume and these parameters. These
parameters are trained with gradient descent in such a way so that the output class score is
consistent with each training image. The pooling layers have fixed functions. There are two
other layers - ReLU layer and Loss layer. ReLU layer increases the nonlinear properties of
the decision function. Loss layer uses different loss functions for different tasks. For example,
to predict a single class of K mutually exclusive classes, Softmax loss is used.
Figure (2.4) Local Connectivity of CNN.
2.3.1 Local Connectivity
CNN enforces a local connectivity pattern between adjacent layer neurons and thus
utilizes spatially-local correlation. Figure 2.4 shows local connectivity in a CNN. Here the
inputs of hidden units of layer m are generated from a subset of units of layer m-1. The units
of layer m-1 have spatially adjacent receptive fields. Let us consider layer m-1 as input. Layer
m units are connected to 3 adjacent neurons in the layer. So we can say that the receptive
field width of layer m is 3. Receptive field width of layer m+1 is also 3 concerning layer m.
But with respect to the input layer, the receptive field width of layer m+1 is 5. Each unit
does not respond to variations outside of its receptive field with respect to the input layer.
So it is ensured that the learned filters will produce the strongest response to a spatially
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local input pattern. Now if we stack multiple layers, then the filters would become global
gradually and response to a larger region of pixel space. As in the figure, we can see neurons
of hidden layer m+1 can encode a feature of width 5.
Figure (2.5) Feature Map.
2.3.2 Shared Weights
One crucial feature of CNN is each filter hi is replicated across the entire visual field.
Same weight and bias are shared by these replicated units, and a feature map is produced. By
sharing the same weights, CNN achieves shift-invariant property. So CNN can detect features
regardless of their position. Sharing weight thus allows CNN to achieve high performance
in recognition and detection problem. The need to learn free parameters is also decreased
significantly, so learning efficiency improves. It also reduces the required memory size. Figure
2.5 shows a feature map consisted of 3 units. We obtain a feature map by repeatedly applying
a function across the sub-regions of the input image that is the convolution of the image with
a linear filter and adding a bias term and applying a non-linear function, σ. The k–th feature
map at a given layer can be denoted as hk. If the filters of feature map hk is determined by
weights Wk and bias bk, then we can write:
hkij = σ((W
k ∗ x)ij + bk) (2.3)
2.3.3 Pooling
Pooling operation reduces the spatial size of the data representation and helps to reduce
the parameters and computation in the network. Max-pooling and average pooling are
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two popular pooling operations. Max pooling is also known as down-sampling. The input
image is partitioned into a set of non-overlapping rectangles. Then for each sub-region, the
maximum value is computed. Since non-maximal values are eliminated, so computation for
upper layers are reduced. Max pooling also provides translation invariance. If we cascade a
max-pooling layer with a convolutional layer, we get eight directions to translate the input
image by a single pixel. Now if max-pooling is done in a 2x2 region, out of the eight possible
configurations, three will provide the same output at the convolutional layer. If the region
size is 3x3, 5 out of 8 regions will give the same output. Because of this robustness, max-
pooling is used to reduce the dimension of intermediate representations. Figure 2.6 presents
an example of max–pooling operation.
Figure (2.6) Max-Pooling Operation. Each Max is Taken Over 4 Numbers Arranged in 2x2
Square.
2.4 Generative Adversarial Networks
Generative Adversarial Networks (GANs) is a deep learning architecture that consisted
of two models - a generative model G and a discriminative model D. The generative model
captures the data distribution. The discriminative model estimates the probability that the
sample is drawn from the training data rather than the generative model. The two models
are simultaneously trained via an adversarial process. The architecture is inspired by game
theory and corresponds to a minimax two-player game. The training procedure of G is to
maximize the probability of D making a mistake [6].
Let the generator G (z, θx) is a differentiable function represented by a multilayer percep-
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tron with parameters θg that depicts a mapping to the data space. To learn the generator’s
distribution ρg over the data space x, a prior ρz is defined on random input noise variables
z. The discriminator D (x, θd) is also a neural network that gets a sample the real dataset
or the generated synthetic dataset produced by G and outputs a single scalar value that
the input data comes from the real training dataset. The training process focuses on the
task that the discriminator D will maximize the probability of assigning correct labels to the
training examples and generated samples from G. At the same time, G is trained to generate
data samples similar to the real dataset so that D cannot differentiate them from actual
data. Similar to game theory, the discriminator D and the generator G play a two-player
mini-max game with following value function V (G,D):
min
G
max
D
V (D,G) = Ex∼ρdata(x) [logD(x)] + Ez∼ρdata(z) [log(1−D(z))] (2.4)
Where x is the real data and z is the input random noise. ρdata, ρz represent the distri-
bution of the real data and the input noise. D(x) represents the probability that x came from
the real data while G(z) represents the mapping to synthesize the real data. The generator,
G is a deeper neural network and have more convolutional layers and nonlinearities. The
noise vector z is upsampled while G learns the weights through backpropagation. At some
point, the generator starts producing data that is classified as real by the discriminator.
Figure (2.7) The Major Components of A Magnetic Resonance Imaging System [1].
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2.5 Magnetic Resonance Imaging
Magnetic Resonance Imaging (MRI) is a technique that creates a 3D representation of
body structures using magnetic fields and radio waves. Nowadays it is a standard practice
to use MRI to detect changes in the body caused by different diseases. Magnetic Resonance
Imaging was developed around 1980. MRI is a powerful imaging technique to visualizing
detailed structures in vivo. MRI technique uses magnetic manipulation of protons to acquire
images without ionizing radiation. In the MRI scanner, the patient is placed in a strong mag-
netic field that causes the hydrogen atoms (protons in the water molecules) in the patients
body to align either in parallel or anti-parallel to the magnetic field.
Figure 2.7 shows the major components of a Magnetic Resonance Imaging system.
Protons are randomly oriented within the water nuclei of the tissue.Radio-frequency (RF)
pulses emitted from the radio-frequency coils in the MRI system causes the proton to spin
on its axis. When the RF pulse is turned off, protons return to their resting alignment and
emit RF energy. The emitted signals are measured after a certain period following the initial
RF to produce the Three Dimensional (3D) grey-scale image. Proton spin relaxation rate
differs depending on their tissue type and decides the intensity level of the image. Different
types of images are created using a different sequence of RF pulses. Repetition Time (TR)
refers to the amount of time between consecutive pulse sequences applied to the same slice.
Time to Echo (TE) indicates the time between the transmission of the RF pulse and the
receipt of the echo signal [1].
Figure (2.8) T1 and T2 Weighted Images of Brain [2].
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T1 and T2 are two commonly used relaxation times for protons. T1 or longitudinal
relaxation time is the measure of time taken for spinning protons to realign with the external
magnetic field. It determines the rate at which excited protons return to equilibrium. T2
or transverse relaxation time is the measure of the time taken for spinning protons to lose
phase coherence among the nuclei spinning perpendicular to the main field. It determines
the rate at which excited protons reach equilibrium or go out of phase with each other [2].
Figure 2.8 shows T1 and T2 weighted images of brain. T1-Weighted MRI is produced with
short TE and short TR (TR <1000 ms, TE <30 ms ) while long TE and long TR (TR >2000
ms, TE >80 ms) is used to obtain T2-weighted images. In a T1-weighted brain MRI, the
Gray Matter (GM) is visible as a dark grey area, the White Matter (WM) is light grey, and
the Cerebrospinal Fluid (CSF) is black. On the other hand, in T2-weighted brain images,
GM is light grey, WM is dark grey, and CSF is bright.
(a) (b) (c)
Figure (2.9) Structural MRI Images Presenting (a) Normal Control; (b) MCI; (c) AD.
2.5.1 Structural MRI (sMRI)
Structural magnetic resonance imaging (sMRI) is used to examine the physical structure
of the brain. It translates the differences in the water content with different shades of grey
and outlines the shape and size of the subregions of the brain. Structural MRI presents good
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tissue contrast that helps to identify changes in the brain such as the presence of tumours.
For our research, we analyze sMRI for Alzheimer’s Disease diagnosis. Figure 2.9 shows
structural MRI images presenting different stages of Alzheimer’s Disease.
2.6 Positron Emission Tomography (PET)
Positron Emission Tomography is a class of nuclear medicine imaging. It is also known
as PET imaging or a PET scan. Nuclear medicine refers to a type of medical imaging meth-
ods that utilizes radioactive material in a small amount to diagnose and determine the stage
of a disease or treat a disease. Nuclear Medicine procedures are known for their ability to
pinpoint molecular activity within the body. So, they have the potential to diagnose the
disease in the earliest stage and find patient’s response to therapeutic interventions. These
procedures are used to diagnose different types of cancers, heart disease, gastrointestinal,
endocrine, neurological disorders and other abnormalities within the body. Radioactive ma-
terials known as radiopharmaceuticals or radiotracers are used to perform nuclear medicine
imaging procedures.
Positron Emission Tomography (PET) uses small amounts of radiotracers, a special cam-
Figure (2.10) Positron Emission Tomography (PET) Scanning Procedure [3].
era and a computer to evaluate the physiological changes. Positron Emission Tomography
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(PET) measures the body changes at the cellular level by looking at blood flow, metabolism,
neurotransmitters, and radiolabelled drugs. PET may identify early onset of disease before
it is evident on other imaging tests. It performs quantitative analyses and finds relative
changes over time as the disease process evolves or in response to a specific stimulus [3].
Figure 2.10 presents the procedure to perform PET scan. Depending on the organ or tissue
to study, the tracer can be injected, swallowed or inhaled. A small amount of a radioactive
tracer is administered into a peripheral vein, and the radioactivity emitted is measured. The
tracer is injected as an intravenous injection usually labelled with oxygen-15, fluorine-18,
carbon-11, or nitrogen-13. The areas of the disease often demonstrate higher levels of chem-
ical activity and the tracer collects in areas of your body. On the PET scan, these areas
might show up as bright spots. The total radioactive dose is similar to the dose used in
Computed Tomography (CT).
(a) (b) (c)
Figure (2.11) Example of Brain PET Images (a) Normal Control (b) MCI (c) AD.
PET imaging tracers can correlate β-amyloid deposition in the brain. The amyloid
deposition in the brain can be detected years before the onset of clinical signs of Alzheimer’s
Disease. The PET imaging tracers can help in differentiating dementia syndromes at the
early stage. PET scans reflect the resting state cerebral metabolic rates of glucose that is an
indicator of neuronal activity. Cerebral glucose metabolic alterations have distinct patterns
that can be used to identify Alzheimer’s Disease symptoms. Fig. 2.11 shows some brain PET
images with different AD stages.
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Chapter 3
REVIEW OF THE STATE-OF-THE-ART
In this section, we review the related work focusing on Alzheimer’s Disease Diagnosis,
synthetic medical image generation and CNN Visualization.
3.1 Alzheimer’s Disease Diagnosis
Detection of physical changes in brain complement clinical assessments and has an
increasingly important role for early detection of AD. Researchers have been devoting
their efforts to Neuroimaging techniques to measure pathological brain changes related to
Alzheimer’s disease. Machine learning techniques have been developed to build classifiers
using imaging data and clinical measures for AD diagnosis [7], [8], [9], [10], [11], [12], [13],
[14], [15], [16]. These studies have identified the significant structural differences in the re-
gions such as the hippocampus and entorhinal cortex between the healthy brain and brain
with AD. Changes in cerebrospinal tissues can explain the variations in the behavior of the
AD patients [17], [18]. Besides, there is a significant connection between the changes in brain
tissues connectivity and behavior of AD patient [19]. The changes causing AD due to the
degeneration of brain cells are noticeable on images from different imaging modalities, e.g.,
structural and functional Magnetic Resonance Imaging (sMRI, fMRI), Position Emission To-
mography (PET), Single Photon Emission Computed Tomography (SPECT), and Diffusion
Tensor Imaging (DTI) scans. Several researchers have used these neuroimaging techniques
for AD Diagnosis. For example, sMRI ([20], [21], [22], [23], [24], [25]), fMRI([26], [27]), PET
([28], [29]), SPECT ([30], [31], [32]), and DTI ([33], [34]) have been used for diagnosis or
prognosis of AD. Moreover, information from multiple modalities have been combined to
improve the diagnosis performance ([35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45],
[46]).
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A classic Magnetic Resonance Imaging (MRI) based automated AD diagnostic sys-
tem has mainly two building blocks - feature/biomarker extraction from the MRI data and
classifier based on those features/biomarkers. Though various types of feature extraction
techniques exist, there are three major categories - (1) voxel-based approach, (2) Region
of Interest (ROI)-based approach, and (3) patch-based approach. Voxel-based approaches
are independent of any hypothesis on brain structures [47], [48], [49], [50]. For example,
voxel-based morphometry measures local tissue (i.e., white matter, gray matter, and cere-
brospinal fluid) density of the brain. Voxel-based approaches exploit the voxel intensities as
the classification feature. The interpretation of the results are simple and intuitive in voxel-
based representations, but they suffer from the over-fitting problem. Since there are limited
(e.g., tens or hundreds) subjects with very high (millions) dimensional features [51], which
is a major challenge for AD diagnosis based on neuroimaging. To achieve more compact
and useful features, dimensionality reduction is essential. Moreover, voxel-based approaches
suffer from the ignorance of regional information.
Region of Interest (ROI)-based approach utilizes the structurally or functionally pre-
defined brain regions and extracts representative features from each region [21], [24], [27],
[28], [52], [53],[54]. These studies are based on specific hypothesis on abnormal regions of
the brain. For example, some studies have adopted gray matter volume [55], hippocampal
volume [56], [57], [58] and cortical thickness [21], [59]. ROI-based approaches are widely used
due to relatively low feature dimensionality and whole brain coverage. But in ROI-based ap-
proaches, the extracted features are coarse as they cannot represent small or subtle changes
related to brain diseases. The structural or functional changes that occur in the brain due
to neurological disorder are typically spread to multiple regions of the brain. As the ab-
normal areas can be part of a single ROI or can span over multiple ROIs, voxel-based or
ROI-based approaches may not efficiently capture the disease-related pathologies. Besides,
the Region of Interest (ROI) definition requires expert human knowledge. Patch-based ap-
proaches [20], [60], [61], [62], [63], [64], [65] divide the whole brain image into small-sized
patches and extract feature vector from those patches. Patch extraction does not require ROI
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identification, so the necessity of human expert involvement is reduced compared to ROI-
based approaches. Compared to voxel-based approaches, patch-based methods can capture
the subtle brain changes with significantly reduced dimensionality. Patch-based approaches
learn from the whole brain and better captures the disease related pathologies that results
in superior diagnosis performance. However, there is still challenges to select informative
patches from the MRI images and generate discriminative features from those patches.
A large number of research works focused on developing advanced machine learning
models for AD diagnosis using MRI data. Support Vector Machine SVM), Logistic Regressors
(e.g., Lasso, and Elastic Net), Sparse Representation based Classification (SRC), Random
Forest Classifier, etc. are some widely used approaches. For example, Kloppel et al. [50]
used linear SVM to detect AD patients using T1 weighted MRI scan. Dimensional reduction
and variations methods were used by Aversen et al. [66] to analyze structural MRI data.
They have used both SVM binary classifier and multi-class classifier to detect AD from
MRI images. Vemuri et al. [67] used SVM to develop three separate classifiers with MRI,
demographic and genotype data to classify AD and healthy patients. Katherine Gray [68]
developed a multi-modal classification model using random forest classifier for AD diagnosis
from MRI and PET data. Amulya et al. [69] used Gray-Level Co-occurrence Matrix (GLCM)
method for AD classification. Morra et al. [70] compared several model’s performances
for AD detection including hierarchical AdaBoost, SVM with manual feature and SVM
with automated feature. For developing these classifiers, typically predefined features are
extracted from the MRI data. However, training a classifier independent from the feature
extraction process may result in sub-optimal performance due to the possible heterogeneous
nature of the classifier and features [71].
Recently, deep learning models have been famous for their ability to learn feature repre-
sentations from the input data. Deep learning networks use a layered, hierarchical structure
to learn increasingly abstract feature representations from the data. Deep learning architec-
tures learn simple, low-level features from the data and build complex high-level features in a
hierarchy fashion. Deep learning technologies have demonstrated revolutionary performance
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in several areas, e.g., visual object recognition, human action recognition, natural language
processing, object tracking, image restoration, denoising, segmentation tasks, audio classi-
fication, brain-computer interaction, etc. In recent years, deep learning models specially
Convolutional Neural Network (CNN) have demonstrated excellent performance in the field
of medical imaging, i.e., segmentation, detection, registration, and classification [72]. For
neuroimaging data, deep learning models can discover the latent or hidden representation
and efficiently capture the disease-related pathologies. So, recently researchers have started
using deep learning models for AD and other brain disease diagnosis.
Gupta et al. [64] have developed a sparse autoencoder model for AD, Mild Cognitive
Impairment (MCI) and healthy control (HC) classification. Payan et al. [65] trained sparse
autoencoders and 3D CNN model for AD diagnosis. They also developed a 2D CNN model
that demonstrated nearly identical performance. Brosch et al. [73] developed a deep belief
network model and used manifold learning for AD detection from MRI images. Hosseini-As
et al. [74] adapted a 3D CNN model for AD diagnostics. Liu et al. [75] developed a deep
learning model using both unsupervised and supervised techniques and classified AD and
MCI patients. Liu et al. [76] have developed a multimodal stacked auto-encoder network
using zero-masking strategy. Their target was to prevent loss of any information of the image
data. They have used SVM to classify the neuroimaging features obtained from MR/PET
data. Sarraf et al. [77] used fMRI data and deep LeNet model for AD detection. Suk et
al. [20], [41], [78], [79] developed an autoencoder network-based model for AD diagnosis
and used several complex SVM kernels for classification. They have extracted low to mid
level features from magnetic current imaging (MCI), MCI-converter structural MRI, PET
data and performed classification using multi-kernel SVM. Ca´rdenas-Pen˜a et al. [80] have
developed a deep learning model using central kernel alignment and compared the supervised
pre–training approach to two unsupervised initialization methods, autoencoders and Princi-
pal Component Analysis (PCA). Their experiment shows that SAE with PCA outperforms
three hidden layers SAE and achieves an increase of 16.2% in overall classification accuracy.
So far, AD is detected at a much later stage when treatment can only slow the pro-
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gression of cognitive decline. No treatment can stop or reverse the progression of AD. So,
early diagnosis of AD is essential for preventive and disease-modifying therapies. Most of
the existing research work on AD diagnosis focused on binary classification problems, i.e.,
differentiating AD patients from healthy older adults. However, for early diagnosis, we need
to distinguish among current AD stages, which makes it a multi-class classification problem.
In our initial work [81], we developed a very deep convolutional network and classified the
four different stages of the AD - nondemented, very mild dementia, mild dementia, and
moderate dementia. We improved the previous model, developed an ensemble of deep con-
volutional neural networks [82], and demonstrated better performance on the Open Access
Series of Imaging Studies (OASIS) dataset [83]. Additionally, we developed an efficient deep
convolutional neural network based classifier [84] and demonstrated better performance on
the ADNI dataset [85].
3.2 Medical Image Synthesis
Medical Image synthesis and Generative Adversarial networks have got attention in re-
cent years. Costa et al. [86] used a fully-convolutional neural network to train on retinal
vessel segmentation images and then applied GANs for generating synthetic retinal images.
Dai et al. [87] used GANs for creating lung fields and heart segmentation images from chest
X-ray images. Shin et al. [88] utilized GANs for generating synthetic abnormal MRI images
with brain tumors. Nie et al. [89], proposed an auto-context model for brain CT and MRI
image refinement. Schlegl et al. [90] trained GANs for anomaly detection in retinal images.
Frid-Adar et al. [91] applied GANs for synthesizing liver lesion ROIs to apply in liver lesion
classification. Hu et al. [92] applied GANs to generate a MRI motion model. Mahapatra
et al. [93] synthesized high-resolution retinal fundus images using generative adversarial
networks. Nie et al. [89] generated synthetic pelvic CT images using GANs.
In our previous research works, we had to handle the limited dataset problem for
Alzheimer’s Disease diagnosis. There is a gap in research work for synthesizing brain images
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for Alzheimer’s Disease diagnosis. Besides, there are very few works done for PET image
synthesis. To mitigate these gaps, we propose a novel model to generate synthetic brain
Positron Emission Tomography (PET) images exploiting Generative Adversarial Networks
for three stages of Alzheimer’s Disease - Normal Control (CN), Mild Cognitive Impairment
(MCI), and Alzheimer’s Disease (AD).
3.3 CNN Visualization
Recently, several visualization methods for CNN interpretation have been proposed.
Some of these methods focus on synthesizing the image that maximizes the score of a given
unit in a pretrained CNN, while others invert feature maps of a conv-layer back to the input
image. Among the gradient-based methods, deconvnet with Occlusion Sensitivity [94], Sensi-
tivity analysis with backpropagation [95], Guided Backpropagation (GB) [96] demonstrated
notable performance. These methods compute the gradients of the score of the convolutional
neural network with respect to the input image. The gradients that maximize the neuron
score are used to estimate the image appearance.
Rieke et al. [97] compared four visualization methods to understand a CNN behavior
for AD diagnosis using MRI data. Bo¨hle et al. [98] presented an approach utilizing Layer-
wise Relevance Propagation (LRP) [99] for CNN visualization for AD diagnosis. Korolev et
al. [100] applied the occlusion method to interpret a deep CNN. They mainly focused on
developing a 3D-CNN classifier and didn’t employ different visualization method. Yang et
al. [11] presented segmentation-based occlusion approach to find visual explanations that
can indicate a 3D-CNNs spatial attention on MRI brain scans when making predictions. To
the best of our knowledge, our work is the first to understand CNN behavior for Alzheimer’s
Disease and Mild Cognitive Impairment diagnosis trained using PET data.
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Chapter 4
A NOVEL DEEP LEARNING BASED MULTI-CLASS CLASSIFICATION
METHOD FOR ALZHEIMER’S DISEASE DIAGNOSIS
4.1 Introduction
In this chapter, we describe our initial work and present a novel deep learning model
for multi-Class Alzheimer’s Disease detection and classification using Brain MRI Data. We
design a very deep convolutional network and demonstrate the performance on the Open
Access Series of Imaging Studies (OASIS) dataset [83]. Fig. 7.1 shows some brain MRI
images presenting different AD stage.
(a) (b) (c) (d)
Figure (4.1) Example of Different Brain MRI Images Presenting Different AD Stage. (a)
Nondemented; (b) very mild dementia ; (c) mild dementia; (d) moderate dementia.
4.2 Method
In this section, the proposed Alzheimer’s disease detection and classification framework
would be presented. The proposed model is shown in Fig. 4.2. Our model is inspired by
Inception-V4 network [101]. After the preprocessing is done, the input is passed through
a stem layer. A stem layer includes several 3*3 convolution layers, 1*1 convolution layer,
and max pooling layer. There is seven 3*3 convolution layer connected in different stages
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and two filter-expansion layers (1*1 convolution layer). Inception-A module has four filter-
expansion layers, three 3*3 convolution layer, and one average pooling layer. Inception-B
module has four filter-expansion layers, four 1*7 convolution layer, two 7*1 convolution layer
and one average pooling layer. Inception-C module has four filter-expansion layers, three 1*3
convolution layer, three 3*1 convolution layer and one average pooling layer. Reduction-A
module has one filter-expansion layer, three 3*3 convolution layer, and one 3*3 max-pooling
layer. The Reduction-B module has two filter-expansion layers, two 3*3 convolution layer,
one 1*7 convolution layer, one 7*1 convolution layer and one 3*3 max pooling layer. The
input and output of all these modules pass through filter concatenation process. We have
redesigned the final softmax layer for Alzheimer’s disease detection and classification. The
softmax layer has four different output class: nondemented, very mild, mild and moderate
AD. The network takes an MRI image as input and extracts layer-wise feature representation
from the first stem layer to the last drop-out layer. Based on this feature representation, the
input MRI image is classified to any of the four output classes.
Figure (4.2) Block Diagram of Proposed Alzheimer’s Disease Detection and Classification
Framework.
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To measure the loss of the proposed network, we have used cross entropy. The Softmax
layer takes the feature representation, fi and interprets it to the output class. A probability
score, pi is also assigned for the output class. If we define the number of Alzheimer’s disease
stages as m, then we get
pi =
exp(f i)∑
i exp(f i)
, i = 1, ...,m
and
L = −
∑
i
tilog(pi),
where L is the loss of cross entropy of the network. Back propagation is used to calculate
the gradients of the network. If the ground truth of an MRI image is denoted as ti, then,
∂L
∂fi
= pi − ti
There is numerous possible combination for the hyper-parameters of a network. It takes
a lot of time and effort to decide a stable hyperparameter set for a network. To reduce this
time, we have used hyperparameters of the Inception-V4 model [101] instead of random
initialization. The weights and biases of the inception-v4 model [101] pre-trained with Ima-
geNet database [102] provide our network an efficient hyperparameter set. As a result, the
model has a sense of better feature detector and can use that knowledge for learning features
from the small medical image dataset. We have trained our model with OASIS [83] dataset.
To prevent overfitting in the network, we have applied data augmentation technique such as
reflection and scaling.
4.3 Data
OASIS dataset is prepared by Dr. Randy Buckner from the Howard Hughes Medical
Institute (HHMI) at Harvard University, the Neuroinformatics Research Group (NRG) at
Washington University School of Medicine, and the Biomedical Informatics Research Net-
work (BIRN) [83]. There are 416 subjects aged 18 to 96, and for each of them, 3 or 4
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T1-weighted MRI scans are available. 100 of the patients having age over 60 are included in
the dataset with very mild to moderate AD. Fig. 4.3 shows some sample brain MRI images
from OASIS dataset.
Figure (4.3) Sample Images From OASIS Dataset.
4.4 Experiments
We have implemented the proposed deep CNN model for Alzheimer’s disease detection
and classification using Tensorflow [30] and Python on a Linux X86-64 machine with AMD A8
CPU, 16 GB RAM and NVIDIA GeForce GTX 770. We have applied data augmentations
techniques - scaling and reflection on the images. Since the dataset is small, 5-fold cross
validation is performed on the dataset. For each fold, We have used 70% as training data,
10% as validation data and 20% as test data. The input size of the Inception-V4 network
[101] is 299*299*3. To fit the MRI data, we have designed the input size of our network as
299*299*1. We have modified the Inception B and C module so that they can accept the
MRI data. The convolutional filter size of Inception-B is 1154 in the original network. We
made it to 1152 to fit the MRI data. The convolutional filter size of Inception-C is 2048 in
the original network. We made it to 2144 to fit the MRI data. The network is optimized
with the RMSProp [103] algorithm and early-stopping is used for regularization. The decay
of the network is 0.9 and batch size is 8. The base learning rate is set to 0.045.
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Table (4.1) Confusion Matrix
AD stage Nondemented Very mild Mild Moderate
Nondemented 52 0 0 0
Very mild 2 4 0 0
Mild 7 0 8 0
Moderate 3 0 1 3
4.4.1 Results
To our best knowledge, our approach is the first one for Alzheimer’s disease detection
and classification using deep learning method on OASIS dataset. So, we are not comparing
it with previous traditional methods. The current accuracy of our method is 73.75%. The
confusion matrix is presented in Table 4.1. The proposed model is much faster and takes
less than 1 hour to train and test the OASIS dataset for Alzheimer’s disease detection and
classification. This performance is superior than all previous traditional methods. It would
take weeks for human experts to analyze and classify all the MRI data. We do not need any
manual hand-crafting for feature generation in our model.
We have implemented another deep model with traditional inception module and 22 lay-
ers following GoogleNet [104] architecture and compared the performance with our proposed
model. The performance comparison is presented in Table 4.2.
Table (4.2) Five-fold Cross Validation Performance Accuracy comparison.
No. of epochs Traditional Inception Network Proposed Model
5 60.00% 71.25%
10 64.25% 73.75%
4.5 Summary
An automated Alzheimer’s disease detection and classification framework is crucial for
the early diagnosis and treatment of the AD patients. Our proposed model is faster, does
not need any handcrafted feature, and can handle the small medical image dataset. We have
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provided a one-step analysis for the brain MRI data for AD detection and classification.
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Chapter 5
ALZHEIMER’S DISEASE DIAGNOSIS USING AN ENSEMBLE SYSTEM
OF DEEP CONVOLUTIONAL NEURAL NETWORKS
5.1 Introduction
In this chapter, we improve our work presented in Part 4 and present an ensemble of deep
Convolutional Neural Networks for Alzheimer’s Disease diagnosis and demonstrate superior
performance on the Open Access Series of Imaging Studies (OASIS) dataset. While most of
the existing approaches perform binary classification, our model can identify different stages
of Alzheimers Disease.
Machine learning studies using neuroimaging data for developing diagnostic tools helped
a lot for automated brain MRI segmentation and classification. Most of them use handcrafted
feature generation and extraction from the MRI data. These hand-crafted features are fed
into machine learning models such as Support Vector Machine, Logistic regression model,
etc. for further analysis. Human experts play a crucial role in these complex multi-step
architectures. Moreover, neuroimaging studies often have a dataset with limited samples.
While image classification datasets used for object detection and classification have millions
of images (for example, ImageNet database [105]), neuroimaging datasets usually contain
a few hundred images. But a large data set is vital to develop robust neural networks.
Because of the scarcity of large image database, it is important to develop models that can
learn useful features from the small dataset. Moreover, The state-of-the-art deep learning
models are optimized to work with natural (every day) images. These models also require
a lot of balanced training data to prevent over-fitting in the network. We developed a
deep convolutional neural network that learned features directly from the input sMRI and
eliminated the need for the hand-crafted feature generation. We trained our model using the
OASIS database [83] that has only 416 sMRI data. Our proposed model can classify different
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stages of Alzheimer’s Disease and outperforms the off-the-shelf deep learning models.
5.2 Method
Let x = {xi, i = 1, ..., N}, a set of MRI data with xi ∈ [0, 1, 2, ..., L − 1]h∗w∗l , a three
Dimensional (3D) image with L gray scale values, h*w*l voxels and y ∈ {0, 1, 2, 3}, one of
the stages of AD where 0, 1, 2, 3 refers to nondemented, very mild dementia, mild dementia,
and moderate dementia respectively. We will construct a classifier,
f : X → Y ; x 7→ y (5.1)
that predicts a label y in response to an input image x with minimum error rate. Mainly,
we want to determine this classifier function f by an optimal set of parameters w ∈ RP
(where P can easily be in the tens of millions), that will minimize the loss or error rate of
prediction. The training process of the classifier would be an iterative process to find the set
of parameters w, that minimizes the classifier’s loss
L(w,X) =
1
n
n∑
i=1
l(f(xi, w), ĉi) (5.2)
where xi is i
th image of X, f(xi, w) is the classifier function that predicts the class ci of xi
given w, ĉi is the ground-truth class for i
th image xi and l(ci, ĉi) is the penalty function for
predicting ci instead of ĉi . We set l to the loss of cross–entropy,
l = −
∑
i
ĉi log ci (5.3)
5.2.1 Data Selection
In this study, we use the OASIS dataset [83] prepared by Dr. Randy Buckner from
the Howard Hughes Medical Institute (HHMI) at Harvard University, the Neuroinformatics
Research Group (NRG) at Washington University School of Medicine, and the Biomedical
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Informatics Research Network (BIRN). There are 416 subjects aged 18 to 96, and for each
of them, 3 or 4 T1-weighted sMRI scans are available. 100 of the patients having age over
60 are included in the dataset with very mild to moderate AD.
5.2.2 Data Augmentation
Data augmentation refers to artificially enlarging the dataset using class-preserving
perturbations of individual data to reduce the overfitting in neural network training [106].
The reproducible perturbations will enable new sample generation without changing the
semantic meaning of the image. Since manually sourcing of additional labeled image is
difficult in medical domain due to limited expert knowledge availability, data augmentation is
a reliable way to increase the size of the dataset. For our work, we developed an augmentation
scheme involving cropping for each image. We set the dimension of the crop similar to the
dimension of the proposed deep CNN classifier. Then, we extracted three crops from each
image, each for one of the image plane: Axial or horizontal plane, Coronal or frontal plane,
and Sagittal or median plane. For our work, we use 80% data from the OASIS dataset as
training set, and 20% as test dataset. From the training dataset, a random selection of
10% images is used as validation dataset. The augmentation process is performed separately
for the train, validation and test dataset. One important thing to consider is the data
augmentation process is different from classic cross–validation scheme. Data augmentation
is used to reduce overfitting in a vast neural network while training with a small dataset.
On the other-hand, cross-validation is used to derive a more accurate estimate of model
prediction performance. Cross-validation technique is computationally expensive for a deep
convolutional neural network training as it takes an extensive amount of time.
5.2.3 Network Architecture
Our proposed network is an ensemble of three deep convolutional neural networks with
slightly different configuration. We made a considerable amount of effort for the design of
the proposed system and the choice of the architecture. All the individual models have a
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Figure (5.1) Illustration of Dense Connectivity with a 5-layer Dense Block.
common architectural pattern consisted of four basic operations:
• convolution
• batch normalization [107]
• rectified linear unit, and
• pooling
Figure (5.2) Illustration of Two Dense Blocks and Their Intermediate Connection.
Each of the individual convolutional neural networks has several layers performing these
four basic operations. The layers in the model follow a particular connection pattern known
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Figure (5.3) Block Diagram of Proposed Alzheimer’s Disease Diagnosis Framework.
as dense connectivity [108] as shown in Fig. 5.1. The dense connections have a regularizing
effect that reduces overfitting in the network while training with a small dataset. We keep
these layers very narrow (e.g., 12 filters per layer) and connect each layer to every other layer.
Similar to [108], we will refer to the layers as dense layer and combination of the layers as
dense block. Since all the dense layers are connected to each other, the ith layer receives the
feature-maps (h0, h1, h2, ..., hi−1), from all previous layers (0, 1, 2, ..., i − 1). Consequently,
the network has a global feature map set, where each layer adds a small set of feature-maps.
In times of training, each layer can access the gradients from the loss function as well as
the original input. Therefore, the flow of information improves, and gradient flow becomes
stronger in the network. Fig. 5.2 shows the intermediate connection between two dense
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blocks.
For the design of the proposed system, we experimented with several different deep learn-
ing architectures and finally developed an ensemble of three homogeneous deep convolution
neural networks. The proposed model is shown in Fig. 5.3. We will refer to the individual
models as M1, M2, and M3. In Fig. 5.3, the top network is M1, the middle network is M2
and the bottom network is M3. Each of the models consists of several convolution layers,
pooling layers, dense blocks and transition layers. The transition layer is a combination of
batch normalization layer, a 1*1 convolutional layer followed by a 2*2 average pooling layer
with stride 2. Batch normalization [107] acts as a regularizer and speeds up the training
process dramatically. Traditional normalization process (shifting inputs to zero-mean and
unit variance) is used as a pre-processing step. Normalization is applied to make the data
comparable across features. When the data flow inside the network at the time of training
process, the weights and parameters are continuously adjusted. Sometimes these adjust-
ments make the data too big or too small; a problem referred as ‘Internal Covariance Shift’.
Batch normalization largely eliminates this problem. Instead of doing the normalization at
the beginning, batch normalization is performed to each mini batches along with SGD train-
ing. If B = {x1, x2, ..., xm} is a mini-batch of m activations value, the normalized values are
(x̂1, x̂2, ..., x̂m) and the linear transformations are y1, y2, ..., ym, then batch normalization is
referred to the transform:
BNγ,β : x1, x2, ..., xm → y1, y2, ..., ym (5.4)
Considering γ, β the parameters to be learned and , a constant added to the mini-batch
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variance for numerical stability, batch normalization is given by the following equations:
µB ← 1
m
m∑
i=1
xi (5.5a)
σ2B ←
1
m
m∑
i=1
(xi − µB)2 (5.5b)
x̂i ← xi − µB√
σ2B + 
(5.5c)
yi ← γx̂i + β ≡ BNγ,β(xi) (5.5d)
where µB is mini-batch mean, σ
2
B is mini-batch variance [107].
Though each model has four dense blocks, they differ in the number of their internal 1*1
convolution and 3*3 convolution layers. The first model, M1, has six (1*1 convolution and
3*3 convolution layers) in the first dense block, twelve (1*1 convolution and 3*3 convolution
layers) in the second dense block, twenty-four (1*1 convolution and 3*3 convolution layers)
in the third dense block and sixteen (1*1 convolution and 3*3 convolution layers) in the
fourth dense block. The second model, M2, and third model, M3, has (6, 12, 32, 32) and (6,
12, 36, 24) arrangement respectively. Because of the dense connectivity, each layer has direct
connections to all subsequent layers, and they receive the feature-maps from all preceding
layers. So, the feature-maps work as global state of the network, where each layer can add
their own feature-map. The global state can be accessed from any part of the network and
how much each layer can contribute to is decided by the growth rate of the network. Since
the feature-maps of different layers are concatenated together, the variation in the input of
subsequent layers increases and results in more efficiency.
The input MRI is 3D data, and our proposed model is a 2D architecture, so we devise
an approach to convert the input data to 2D images. For each MRI data, we created patches
from three physical planes of imaging: Axial or horizontal plane, Coronal or frontal plane,
and Sagittal or median plane. These patches are fed to the proposed network as input.
Besides, this data augmentation technique increases the number of samples in training data
set. The size of each patch is 112*112. We trained the individual models separately and
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each of them has own Softmax layer for classification decision. The Softmax layers have four
different output classes: nondemented, very mild, mild, and moderate AD. The individual
models take the input image and generate its learned representation. The input image is
classified to any of the four output classes based on this feature representation. To measure
the loss of each of these models, we used cross entropy. The Softmax layer takes the learned
representation, fi and interprets it to the output class. A probability score, pi is also assigned
for the output class. If we define the number of output classes as m, then we get
pi =
exp(f i)∑
i exp(f i)
, i = 1, ...,m (5.6)
and
L = −
∑
i
tilog(pi) (5.7)
where L is the loss of cross entropy of the network. Back propagation is used to calculate
the gradients of the network. If the ground truth of an MRI data is denoted as ti, then,
∂L
∂fi
= pi − ti (5.8)
To handle the imbalance in the dataset, we used cost sensitive training [109]. A cost matrix
ξ was used to modify the output of the last layer of the individual networks. Since the less
frequent classes (very mild dementia, mild dementia, moderate dementia) are underrepre-
sentated in the training dataset, the output of the networks were modified using the cost
matrix ξ to give more importance to these classes. If o is the output of the individual model,
p is the desired class and L is the loss function, then y denotes the modified output:
yi = L(ξp, o
i), : yip ≥ yij∀j 6= p (5.9)
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The loss function is modified as:
L = −
∑
n
tnlog(yn) (5.10)
where yn incorporates the class-dependent cost ξ and is related to the output on via the
softmax function [109]:
yn =
ξp,nexp(on)∑
k ξp,kexp(ok)
(5.11)
The weight of a particular class is dependent on the number of samples of that class. If class
r has q times more samples than those of s, the target is to make one sample of class s to be
as important as q samples of class r. So, the class weight of s would be q times more than
the class weight of r.
We optimized the individual models with the Stochastic Gradient Descent (SGD) al-
gorithm. For regularization, we used early-stopping. We split the training dataset into a
training set and a cross validation set in 9:1 proportion. Let Ltr(t) and Lva(t) is the aver-
age error per example over the training set and validation set respectively, measured after t
epoch. Training was stopped as soon as it reached convergence, i.e., validation error Lva(t)
does not improve for t epoch and Lva(t) > Lva(t − 1). We used Nesterov momentum opti-
mization with Stochastic Gradient Descent (SGD) algorithm for minimizing the loss of the
network. Given an objective function f(θ) to be minimized, classic momentum is given by
the following pair of equations:
vt = µvt−1 − ∇f(θt−1) (5.12a)
θt = θt−1 + vt (5.12b)
where vt refers to the velocity,  > 0 is the learning rate, µ ∈ [0, 1] is the momentum
coefficient, and ∇fθt is the gradient at θt. On the other hand, Nesterov momentum is given
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by:
vt = µvt−1 − ∇f(θt−1 + µvt−1) (5.13a)
θt = θt−1 + vt (5.13b)
The output classification labels of the three individual model are ensembled together using
majority voting technique. Each classifier “votes” for a particular class, and the class with
the majority votes would be assigned as the label for the input MRI data.
Figure (5.4) Block Diagram of Individual Model M4.
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Figure (5.5) Block Diagram of Individual Model M5.
5.3 Experiments
We implemented the proposed model using Tensorflow [110], Keras[111] and Python on
a Linux X86-64 machine with AMD A8 CPU, 16 GB RAM and NVIDIA GeForce GTX 770.
We applied the SGD training with a mini-batch size of 64, a learning rate of 0.01, a weight
decay of 0.06 and a momentum factor of 0.9 with Nesterov optimization. We applied early
stopping in the SGD training process while there was no improvement (change of less than
0.0001) in validation loss for last six epoch.
To validate the effectiveness of the proposed AD detection and classification model, we
developed two baseline deep CNN, Inception-v4 [112] and ResNet [113] and modified their
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architecture to classify 3D brain MRI data. Besides, we developed two different models, M4
and M5 having similar architecture like M1, M2, and M3 model except for the number of
layers in the dense block. M4, has six (1*1 convolution and 3*3 convolution layers) in the
first dense block, twelve (1*1 convolution and 3*3 convolution layers) in the second dense
block, forty-eight (1*1 convolution and 3*3 convolution layers) in the third dense block and
thirty-two (1*1 convolution and 3*3 convolution layers) in the fourth dense block (Fig. 5.4).
The layers in the dense blocks of M5 has the arrangement 6, 12, 64, 48 as shown in Fig. 5.5.
Additionally, we implemented two variants of our proposed model using M4 and M5.
• For the first variant, we implemented an ensemble of four deep convolutional neural
networks: M1, M2, M3, and M4. We will refer to this model as E1.
• For the second variant, we implemented an ensemble system of five deep convolutional
neural networks: M1, M2, M3, M4 and M5. We will refer to this model as E2.
Four metrics are used for quantitative evaluation and comparison, including accuracy,
positive predictive value (PPV) or precision, sensitivity or recall, and the harmonic mean of
precision and sensitivity (f1–score). We denote TP, TN, FP, and FN as True Positive, True
Negative, False Positive and False Negative, respectively. The evaluation metrics are defined
as:
accuracy = (TP+TN)
(TP+FP+FN+TN)
precision = TP
(TP+FP )
recall = TP
(TP+FN)
f1− score = (2TP )
(2TP+FP+FN)
Table (5.1) Classification Performance of M1 Model.
Class Precision Recall F1–Score Support
Non-Demented 0.99 0.99 0.99 73
Very Mild 0.75 0.50 0.60 6
Mild 0.62 0.71 0.67 7
Moderate 0.33 0.50 0.40 2
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Table (5.2) Classification Performance of M2 Model.
Class Precision Recall F1–Score Support
Non-Demented 0.88 0.95 0.91 73
Very Mild 0.00 0.00 0.00 6
Mild 0.25 0.29 0.27 7
Moderate 0.00 0.00 0.00 2
5.3.1 Results
We report the classification performance of M1, M2, M3, M4, and M5 model in Table 5.1,
Table 5.2, Table 5.3, Table 5.4, and Table 5.5, respectively. From the results, we notice that
M1, M2, and M3 model are the top performers among all models. So, we choose the ensemble
of M1, M2, M3 for our final architecture. Besides, the variants E1 (M1+M2+M3+M4), and
E2 (M1+M2+M3+M4+M5) demonstrates inferior performance compared to the ensemble of
M1, M2, M3 (proposed model) as shown in Fig. 5.6. From Fig. 5.6, we notice that E1 model
has an accuracy of 78% with 68% precision, 78% recall, and 72% f1–score. On the other
hand, the E2 model demonstrates 77% accuracy with 73% precision, 77% recall, and 75%
f1–score.
Table (5.3) Classification Performance of M3 Model.
Class Precision Recall F1–Score Support
Non-Demented 0.99 0.96 0.97 73
Very Mild 0.50 0.33 0.40 6
Mild 0.45 0.71 0.56 7
Moderate 0.50 0.50 0.50 2
Table (5.4) Classification Performance of M4 Model.
Class Precision Recall F1–Score Support
Non-Demented 0.92 0.67 0.77 73
Very Mild 0.00 0.00 0.00 6
Mild 0.17 0.60 0.26 7
Moderate 0.00 0.00 0.00 2
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Table (5.5) Classification Performance of M5 Model.
Class Precision Recall F1–Score Support
Non-Demented 0.80 0.94 0.86 73
Very Mild 0.00 0.00 0.00 6
Mild 0.22 0.14 0.17 7
Moderate 0.00 0.00 0.00 2
Table (5.6) Performance of the Proposed Ensembled Model.
Class Precision Recall F1–Score Support
Non-Demented 0.97 1.00 0.99 73
Very Mild 1.00 0.33 0.50 6
Mild 0.67 0.86 0.75 7
Moderate 0.50 0.50 0.50 2
Table 5.6 shows the per-class classification performance of our proposed ensembled
model on the OASIS dataset [83]. The accuracy of the proposed model is 93.18% with
94% precision, 93% recall and 92% f1–score. The performance comparison of classification
results of the proposed ensemble model and the two baseline deep CNN models are presented
in Fig. 5.7. Inception-v4 [112] and ResNet [113] have demonstrated outstanding performance
for object detection and classification. The reason behind their poor performance for AD
detection and classification can be explained by the lack of enough training dataset.
Figure (5.6) Performance Comparison of the Proposed Model and the Variants.
Since these two networks are very deep neural networks, so without a large dataset,
training process would not work correctly. On the other hand, the depth of our model is
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Figure (5.7) Performance Comparison of the Proposed Model and the Baseline Deep CNNs.
Figure (5.8) Comparison of Accuracy on the OASIS Dataset.
relatively low, and all the layers are connected to all preceding layers. So, there is a strong
gradient flow in times of training that eliminates the ‘Vanishing gradient’ problem. In each
training iteration, all the weights of a neural network receive an update proportional to the
gradient of the error function concerning the current weight. But in some cases, the gradient
will be vanishingly small and consequently prevent the weight from changing its value. It
may completely stop the neural network from further training in worst case scenario. Our
proposed model does not suffer this ‘Vanishing gradient’ problem, have better feature prop-
agation and provides better classification result even for the small dataset. The performance
comparison of classification results of the proposed ensembled model, the baseline deep CNN
models and the most recent work, ADNet [81] is presented in Figure 5.8. It can be observed
that proposed ensembled model achieves encouraging performance and outperforms the other
models.
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5.4 Summary
We made an efficient approach to AD diagnosis using brain MRI data analysis. While
the majority of the existing research works focuses on binary classification, our model pro-
vides significant improvement for multi-class classification. Our proposed network can be
very beneficial for early-stage AD diagnosis. Though the proposed model has been tested
only on AD dataset, we believe it can be used successfully for other classification problems
of medical domain. Moreover, the proposed approach has strong potential to be used for
applying CNN into other areas with a limited dataset. In future, we plan to evaluate the
proposed model for different AD datasets and other brain disease diagnosis.
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Chapter 6
DEEP CONVOLUTIONAL NEURAL NETWORKS FOR AUTOMATED
DIAGNOSIS OF ALZHEIMER’S DISEASE AND MILD COGNITIVE
IMPAIRMENT
6.1 Introduction
In this chapter, we consider the automated diagnosis of Alzheimer’s Disease (AD) and
Mild Cognitive Impairment (MCI) in 3D structural MRI brain scans. We develop an effi-
cient deep convolutional neural network (CNN) based classifier by analyzing 3D brain MRI.
The proposed model extracts features from the MRI scans and learns significant information
related to Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI). We perform
motion correction, non-uniform intensity normalization, Talairach transform, intensity nor-
malization, and skull-stripping in the raw MRI scans. After that several 2D slices are gener-
ated, and center patch is cropped from the slices before passing them to the CNN classifier.
Besides, we demonstrate ways to improve the performance of a CNN classifier for AD and
MCI diagnosis. We conduct experiments using Alzheimer’s Disease Neuroimaging Initia-
tive (ADNI) dataset for classification of the AD, MCI and CN (normal/healthy controls) to
evaluate the proposed model. The proposed model achieves 94.97% accuracy for AD/CN
classification and 91.98% accuracy for AD/MCI classification outperforming baseline models
and several competing methods from other studies.
AD is the most prevailing type of dementia, and Mild Cognitive Impairment (MCI) is
considered as the earlier stage of AD. It is crucial to detect patient at MCI stage before the
disease progress further as there is no cure for AD. Earlier diagnosis can help for proper
1Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging
Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to
the design and implementation of ADNI and/or provided data but did not participate in analysis or writing
of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/
wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
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treatment and prevent brain tissue damage. The Hippocampus and cerebral cortex of the
brain are shrunk, and ventricles are enlarged in the brain of AD patient. Hippocampus
reduction causes cell loss and damages the synapses and neuron ends. Structural MRI
(sMRI) is helpful for measuring these progressive changes in the brain due to the AD.
6.2 Method
Let x = {xi, i = 1, ..., N}, a set of MRI data with xi ∈ [0, 1, 2, ..., L − 1]h∗w∗l , a three
Dimensional (3D) image with L gray scale values, h*w*l voxels and y ∈ {0, 1, 2}, one of the
stages of AD where 0, 1, 2 refers to normal/healthy control (CN), Mild Cognitive Impairment
(MCI), and Alzheimer’s Disease (AD) respectively. We will construct a classifier,
f : X → Y ; x 7→ y (6.1)
that predicts a label y in response to an input image x with minimum error rate. The
training process of the classifier would be an iterative process to find the set of parameters
w, that minimizes the classifier’s loss
L(w,X) =
1
n
n∑
i=1
l(f(xi, w), ĉi) (6.2)
where xi is i
th image of X, f(xi, w) is the classifier function that predicts the class ci of xi
given w, ĉi is the ground-truth class for i
th image xi and l(ci, ĉi) is the penalty function for
predicting ci instead of ĉi . We set l to the loss of cross–entropy,
l = −
∑
i
ĉi log ci (6.3)
6.2.1 Data Selection
For our proposed model, we have used 1726 MRI scans (347 AD, 537 CN, 806 MCI)
of 479 patients from the Alzheimers Disease Neuroimaging Initiative (ADNI) database
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(adni.loni.usc.edu). Specifically We used ADNI1:Annual 2 Yr 1.5T dataset for our model.
The subjects were in the age range 55-92. The ADNI was launched in 2003 as a public-
private partnership, led by Principal Investigator Michael W. Weiner, MD. The primary
goal of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron
emission tomography (PET), other biological markers, and clinical and neuropsychological
assessment can be combined to measure the progression of mild cognitive impairment (MCI)
and early Alzheimers disease (AD). Up-to-date information related ADNI database can be
found at www.adni-info.org.
6.2.2 Data Preprocessing
We downloaded the raw Neuroimaging Informatics Technology Initiative (NiFTI) file
format MRI scans from the ADNI website (http://adni.loni.usc.edu/). The structural MRI
scans were acquired from 1.5T scanners. These MRI scans were already reviewed for quality
and Gradient inhomogeneity correction (gradwarp), B1 non-uniformity correction, and N3
processing (to reduce residual intensity non-uniformity) were applied. Since the raw scans
are not skull-stripped and have unnecessary information, we perform cortical reconstruc-
tion with Freesurfer image analysis suite (http://surfer.nmr.mgh.harvard.edu/). We use the
function recon-all -autorecon1 which performs 5 out of 31 transformation processes done
by Freesurfer. The five transformation processes are - Motion Correction and Conform,
NonUniform intensity normalization (NU), Talairach transform computation, Intensity Nor-
malization 1 and Skull Stripping. After these preprocessing steps we get a skull-stripped
MRI scan with dimension 256*256*256. Some slices from sample skull-stripped MRI scan of
CN, MCI, and AD patients are shown in Fig. 6.2. We discard several slices at the beginning
Figure (6.1) 3D Brain MRI Preprocessing module.
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure (6.2) Skull-Stripped MRI Slices Presenting Different AD Stages. (a)-(c) CN; (d)-(f)
MCI; (g)-(i) AD.
Figure (6.3) Block Diagram of the Proposed Alzheimer’s Disease Diagnosis Framework.
and at the end as they do not have any useful information. After that, we crop a 224*224
center patch from each slice to reduce the background image region outside the brain tissue
and perform image normalization.
6.2.3 Data Augmentation
Data augmentation helps to increase the size of the dataset. For our work, we developed
an augmentation scheme involving generating multiple slices from each MRI scan. Slices are
taken from different image plane: Axial or horizontal plane, Coronal or frontal plane, and
Sagittal or median plane. Moreover, we applied Horizontal Flipping to increase the amount
of training samples.
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Figure (6.4) Deep CNN Architecture Used for the Proposed Alzheimer’s Disease Diagnosis
Framework.
6.2.4 Network Architecture
Fig. 6.3 shows our proposed model for Alzheimer’s Disease diagnosis. The first stage
of the pipeline is the preprocessing module illustrated in Fig. 6.1 and described above. The
second stage of the classifier is a deep convolutional neural network as shown in Fig. 6.4. The
CNN model is a 2D network and follows a modified architectural pattern of DenseNet-121
[108]. The CNN classifier has several layers performing the convolution, batch normalization,
rectified linear unit, and pooling operation. The layers follow a particular connection pattern
known as dense connectivity [108]. We keep these layers very narrow (e.g., 12 filters per layer)
and connect each layer to every other layer. Similar to [108], we will refer to the layers as
dense layer and combination of the layers as dense block. Since all the dense layers are
connected to each other, the ith layer receives the feature-maps (h0, h1, h2, ..., hi−1), from all
previous layers (0, 1, 2, ..., i− 1). The network has a global feature map set, where each layer
adds a small set of feature-maps. Each layer can access the gradients from the loss function
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Table (6.1) Impact of Different Factors on Proposed CNN
Methods
AD vs CN
Accuracy Sensitivity Specificity
Without Pre-training 75.98 78.45 71.43
Random slice 75.98 79.51 68.42
Axial slice 87.15 86.44 88.52
Sagittal slice 89.94 87.10 96.36
Coronal slice 94.97 94.33 95.89
Table (6.2) Impact of Different CNN Architecture on Proposed Diagnosis Framework
Methods
AD vs CN
Accuracy Sensitivity Specificity
ResNet-18 86.03 85.12 87.93
ResNet-50 82.68 85.09 78.46
ResNet-101 83.79 88.18 76.81
ResNet-152 82.68 79.67 89.28
DenseNet-169 83.24 84.35 81.25
DenseNet-201 83.80 88.03 75.81
Proposed method 94.97 94.33 95.89
and the original input in training time. As a result, the flow of information improves, and
gradient flow becomes stronger in the network. Final classification is performed by the
softmax layer with three different output classes: CN, MCI, and AD. We optimized the
CNN classifier using the Adam algorithm [114].
6.3 Experiments
For our work, we used 80% data from the ADNI1 dataset as training set, and 20% as test
dataset. From the training dataset, a random selection of 10% images is used as validation
dataset. The experiments were performed using PyTorch framework. Transfer learning [115]
was applied to pre-train the CNN classifier using Imagenet database [105]. The parameters
used for training process are: learning rate: 0.0001, weight decay: 0.1 after every 7 epochs,
and batch size: 16.
To improve the performance of CNN for AD diagnosis from 3D brain MRI, we studied
the impact of several factors such as - network pre-training, image pre-processing, choosing
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Table (6.3) Comparison with the State-of-the-Art. ‘–’ indicates that result was not reported
by the authors.
Methods
AD vs CN AD vs MCI MCI vs CN
Accuracy Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy Sensitivity Specificity
Sergey et al. [100] 80.00
Beheshti et al. [116] 93.01 89.13 96.80
JLLR+DeepESRNET [117] 91.02 92.72 89.94 73.02 77.60 68.22
MOLR+DeepESRNET [117] 90.28 92.65 89.05 74.20 78.74 66.30
B. Shi et al. [118] 91.95 89.49 93.82 83.72 84.74 82.72
Liu et al. [61] 92.0 90.9 93.0 85.3 82.3 88.2
Aderghal et al. [119] 91.41 89.06 93.75 69.53 67.19 71.88 65.62 66.25 65.00
Proposed method 94.97 94.33 95.89 91.98 90.47 95.38 74.70 70.96 78.20
random slice from the MRI as network input, and choosing specific slice from three different
image plane (axial, sagittal, and coronal).
6.3.1 Results
Initially, we trained the network with raw MRI scans. For this approach, training
accuracy was more than 95%, but validation accuracy was around 68% which indicates the
network lacks generalization. Pre-processed MRI data helped to solve this issue and improved
performance of the CNN. Table 6.1 demonstrates the results of other experiments. From
the results, we can see that choosing random slice from the MRI hampers the performance
of the CNN classifier even with pre-trained network and pre-processed data. Moreover, the
experimental results demonstrate that choosing slices from coronal view have a huge positive
impact on the CNN classifier for AD diagnosis. Table 6.2 shows the effect of different CNN
architecture on the performance of the proposed AD diagnosis framework. Here, it is evident
that the proposed CNN classifier, shown in Fig. 7.2 outperforms the other baseline models.
Our model is pre-trained with the Imagenet database [105] and we perform the training with
the pre-processed coronal slices. These results also demonstrate that the performance of a
CNN classifier vastly depends on the architecture and depth of the network. To validate
the effectiveness of our model, we compare it with several state-of-the-art methods. The
comparison result is shown in Table 6.3. Following previous approaches, we use accuracy,
sensitivity and specificity for performance comparison. The result shows that our model
outperforms other competing methods for AD/CN classification, AD/MCI classification and
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demonstrates comparable performance for MCI/CN classification.
6.4 Summary
We proposed a novel automated Alzheimer’s Disease diagnosis framework and demon-
strated ways to improve the performance of a CNN classifier. The experimental result shows
that a pre-trained network with preprocessed slices from coronal view is a reliable technique
for MCI and AD diagnosis. The performance of the proposed model shows that it can
compete with other state-of-the-art methods for AD diagnosis using 3D brain MRI data.
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Chapter 7
GAN-BASED SYNTHETIC BRAIN PET IMAGE GENERATION
7.1 Introduction
In recent days, deep learning technologies have achieved tremendous success in com-
puter vision related tasks with the help of large scale annotated dataset. Obtaining such
dataset for medical image analysis is very challenging. Working with the limited dataset and
small amount of annotated samples makes it difficult to develop a robust automated disease
diagnosis model. We propose a novel approach to generate synthetic medical images using
Generative Adversarial Networks (GANs). Our proposed model can create brain PET im-
ages for three different stages of Alzheimer’s Disease - Normal Control (CN), Mild Cognitive
Impairment (MCI), and Alzheimer’s Disease (AD).
Developing AI assisted automated disease diagnosis systems using medical images often
requires a large training dataset with annotated samples, especially for supervised learning
methods. Experts with good knowledge of the specific data and task are needed for perform-
ing such annotations. So, medical image annotation process is expensive in terms of time,
money and effort. It becomes more challenging for precise annotations, such as for identi-
fying different stages of Alzheimer’s Disease. If diagnostic images are intended to be made
public, patient consent may be necessary depending on the institutional protocols [120]. So
there are very few public medical datasets available online, and they are still limited in size
and quality. Collecting medical images for developing automated computer-aided diagnosis
system is a complicated and expensive procedure and requires adequate funding, handling
1Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging
Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to
the design and implementation of ADNI and/or provided data but did not participate in analysis or writing
of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/
wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
61
privacy concern, and collaboration of researchers, physicians, and hospitals. Medical datasets
are often imbalanced as pathologic findings are usually rare, and it creates another challenge
to train the automated diagnosis system.
(a) (b) (c)
Figure (7.1) Example of Brain PET images (a) Sagittal View (b) Coronal View (c) Axial
View.
Data augmentation is one way to overcome the problem of limited dataset. There are
several data augmentation techniques, such as translation, rotation, scale, flip, etc. But
these techniques are not as useful for medical image analysis as they are for natural image
dataset. On the contrary, techniques such as translation and rotation might change the pat-
tern useful for the diagnosis. Besides, these images resemble a great extent to the original
ones. So the ML model using these augmented data gain little performance improvements
due to the lack of generalization abilities. Another type of data augmentation strategy is
synthetic data generation. A synthetic dataset is generated programmatically. Such dataset
is highly beneficial for medical image analysis. There is no patient data handling or privacy
concerns as the data is produced synthetically. The dataset can contain samples from both
positive and negative classes for diagnosis purpose and help build a generalized model.
Generative Adversarial Networks (GANs) [6] can generate synthetic data with good
generalization ability. GAN has two different networks - Generator and Discriminator. The
model is trained in an adversarial process where the Generator generates fake images, and
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Figure (7.2) Proposed Synthetic Brain PET Image Generator.
the Discriminator learns to discriminate between the real and fake images. There are some
excellent research works by the computer vision community to generate synthetic data by
using Generative Adversarial Networks [121], [122], [123], [124], [125]. The success of the
vision community for synthetic data generation using GAN and the limitation of medical
data inspired us to explore methods suitable for medical image synthesis. In this study, we
focus on synthetic brain Positron Emission Tomography (PET) image generation for differ-
ent stages of Alzheimer’s Disease - Normal Control (CN), Mild Cognitive Impairment (MCI),
and Alzheimer’s Disease (AD).
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Figure (7.3) Generator Architecture of the Proposed Model.
7.2 Method
7.2.1 Data Selection
For our proposed model, we have used 411 PET scans (98 AD, 105 CN, 208 MCI) of
479 patients. We collected the data from the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) database (adni.loni.usc.edu). Specifically We used ADNI1 baseline dataset for our
model. The subjects were in the age range 55-92. The ADNI was launched in 2003 as
a public-private partnership, led by Principal Investigator Michael W. Weiner, MD. The
primary goal of ADNI has been to test whether serial magnetic resonance imaging (MRI),
positron emission tomography (PET), other biological markers, and clinical and neuropsy-
chological assessment can be combined to measure the progression of mild cognitive im-
pairment (MCI) and early Alzheimer’s disease (AD). Up-to-date information related ADNI
database can be found at www.adni-info.org.
7.2.2 Generative Adversarial Networks
Generative Adversarial Networks (GANs) is a deep learning architecture that consisted
of two models - a generative model G and a discriminative model D. The generative model
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Figure (7.4) Discriminator Architecture of the Proposed Model.
captures the data distribution. The discriminative model estimates the probability that the
sample is drawn from the training data rather than the generative model. The two models
are simultaneously trained via an adversarial process. The architecture is inspired by game
theory and corresponds to a minimax two-player game. The training procedure of G is to
maximize the probability of D making a mistake [6].
Let the generator G (z, θx) is a differentiable function represented by a multilayer percep-
tron with parameters θg that depicts a mapping to the data space. To learn the generator’s
distribution ρg over the data space x, a prior ρz is defined on random input noise variables
z. The discriminator D (x, θd) is also a neural network that gets a sample the real dataset
or the generated synthetic dataset produced by G and outputs a single scalar value that
the input data comes from the real training dataset. The training process focuses on the
task that the discriminator D will maximize the probability of assigning correct labels to the
training examples and generated samples from G. At the same time, G is trained to generate
data samples similar to the real dataset so that D cannot differentiate them from actual
data. Similar to game theory, the discriminator D and the generator G play a two-player
mini-max game with following value function V (G,D):
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Figure (7.5) Visualization of the Generator Output in the Training Process.
min
G
max
D
V (D,G) = Ex∼ρdata(x) [logD(x)] + Ez∼ρdata(z) [log(1−D(z))]
(7.1)
Where x is the real data and z is the input random noise. ρdata, ρz represent the distri-
bution of the real data and the input noise. D(x) represents the probability that x came from
the real data while G(z) represents the mapping to synthesize the real data. The generator,
G is a deeper neural network and have more convolutional layers and nonlinearities. The
noise vector z is upsampled while G learns the weights through backpropagation. At some
point, the generator starts producing data that is classified as real by the discriminator.
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(a) Real Images
(b) Synthetic Images
Figure (7.6) Real and Synthetic Brain PET Images of Normal Patient (a) Real (b) Synthetic.
7.2.3 Deep Convolutional Generative Adversarial Networks (DCGANs)
Deep Convolutional Generative Adversarial Networks (DCGAN) [126] is a major im-
provement on the first GAN [6]. DCGAN can generate better quality images and have more
stability during the training stage. In the synthetic image generation process using the DC-
GAN, there are two phases: a learning phase and a generation phase. In the training phase,
the generator draws samples from an N-dimension normal distribution and works on this
random input noise vector by successive upsampling operations, eventually generating an
image from it. The discriminator attempts to distinguish between images drawn from the
generator and images from the training set [126].
Two important features in DCGAN are BatchNorm ([107] for regulating the extracted
feature scale, and LeakyRelu [127] for preventing dead gradients. DCGAN also replace all
max pooling with convolutional stride and use transposed convolution for upsampling. It
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(a) Real Images
(b) Synthetic Images
Figure (7.7) Real and Synthetic Brain PET Images of MCI Patient (a) Real (b) Synthetic.
eliminates fully connected layers and uses Batch normalization. DCGAN uses ReLU in the
generator except for the output which uses Tanh and uses LeakyReLU in the discriminator.
7.2.4 Proposed Model
We propose a novel approach to produce synthetic PET images using a Deep Convolu-
tional Generative Adversarial Networks. Following the guidelines to construct the generator
and discriminator, described in the paper written by Radford et al. [126], we implemented
and trained them on PET scan images using the original discriminator and generator cost
functions. Fig. 7.2 shows the proposed synthetic PET image generator model.
Generator Architecture The input of the generator is a vector of random 100
numbers drawn from a uniform distribution, and the output is a brain PET image of size
128*128*3. The generator architecture is shown in Fig. 7.3. The network has a fully con-
nected layer and five strided convolutional transpose (known also as ‘deconv’) layers. The
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strided convolutional transpose layers transform the latent vector into a volume with shape
128*128*3. Each convolutional-transpose layer is paired with a 2D batch norm layer and
a ReLU activation. The strided convolutional transpose layer inserts zeros in between the
pixels of the input vector and expands it. The convolution operation is performed over the
enlarged vector to create bigger output data. Normalizing responses to have zero mean and
unit variance over the entire mini-batch are applied to stabilize the learning process. Fig. 7.5
shows the output of different steps from the generator of the proposed model.
Discriminator Architecture The discriminator network consists of a CNN archi-
tecture that takes an image of size 128*128*3 (brain PET image) as input, and outputs one
decision: is the brain PET image real or fake? The network consists of five convolution
layers with a kernel size of 5*5 and a fully connected layer. Strided convolutions are applied
to each convolutional layer to reduce spatial dimensionality instead of using pooling layers.
Batch-normalization and Leaky ReLU activation are applied to each convolutional layer of
the network except the output layer. The fully connected output layer has a Sigmoid func-
tion to generate the likelihood probability (0,1) score of the input image to be real or fake.
The discriminator architecture is shown in Fig. 7.4.
Training Procedure We trained the proposed model to synthesize brain PET images
for three stages of Alzheimer’s Disease separately. The training process was done iteratively
for the generator and the discriminator. We used mini-batches of m = 64 brain PET exam-
ples for each stage (CN, MCI, and AD) and m = 64 noise samples drawn from a uniform
distribution between [-1, 1]. In the Leaky ReLU, the slope of the leak was set to leak = 0.2.
We initialized the weights to a zero-centred normal distribution with a standard deviation
of 0.02. Stochastic gradient descent was used in the training process with the Adam opti-
mizer, an adaptive moment estimation that incorporates the first and second moments of
the gradients, controlled by parameters β1 = 0.5 and β2 = 0.999 respectively. We applied a
learning rate of 0.0001 for 500 epochs.
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(a) Real Images
(b) Synthetic Images
Figure (7.8) Real and Synthetic Brain PET Images of AD Patient (a) Real (b) Synthetic.
In the training process, the discriminator is trained to maximize the probability of as-
signing correct labels to the training examples and the generated samples. At first, the
discriminator gets a batch of real samples from the training set. The batch is forward passed
through D, and the loss (log(D(x))) is calculated. The gradients are calculated in a back-
ward pass. Then, a batch of fake samples from the generator is forward passed through
D. Similarly, the loss (log(1 − D(G(z)))) is calculated, and the gradients are accumulated
with a backward pass. Finally, the gradients from both the all-real and all-fake batches are
summed up, and a step of the Discriminators optimizer is done.
The Generator is trained to generate better fake samples by minimizing log(1 −
D(G(z))). The training process maximizes log(D(G(z))) to minimize the generator’s loss
log(1 − D(G(z))). The output of the generator is passed to the discriminator, and the
classification result is collected. The training process repeats unless the generator learns to
generate samples labelled as real by the Discriminator.
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Figure (7.9) 2D-Histograms of the Synthetic and Real Images. Top Row: 2D-Histogram of
Real images. Bottom Row: 2D-Histogram of Synthetic Images.
7.3 Experiments and Results
It is an open issue to develop objective metrics that correlate with perceived quality
measurement. For quality evaluation of synthetic images, it should be specific for each
application. Following previous state-of-the-art, we performed a quantitative and qualitative
assessment of our proposed model. To our best knowledge, no previous works attempted to
generate synthetic brain PET images using real PET images. We quantitatively compare the
predicted results in terms of Peak Signal to Noise Ratio (PSNR) and Structural Similarity
Index(SSIM). PSNR is used to measure the ratio between the maximum possible intensity
value and the mean squared error of the synthetic and the real image:
PSNR = 10log10
(max(y))2
1
n
∑n
i (yi−yˆi)2
(7.2)
where n is the number of pixels in an image. For our proposed model, the mean PSNR of
real and generated images is 32.83.
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Structural Similarity Index (SSIM) finds the similarities within pixels of two image; i.e.
if the pixels in the two images line up and or have similar pixel density values:
(x, y) =
(2µxµy + C1) + (2σxy + C2)
(µ2x + µ
2
y + C1)(σ
2
x + σ
2
y + C2)
(7.3)
where x is the estimated PET and y is the ground truth PET, µx is the average of x, µy is
the average of y, µ2x is the variance of x, µ
2
y is the variance of y, σxy is the covariance of x and
y. C1 = (k1L)
2 and C2 = (k2L)
2 are used to stabilize the division with weak denominator
where L is the dynamic range of the pixel-values, k1 = 0.01 and k2 = 0.03. For our proposed
model, the mean SSIM of real and generated images is 77.48.
We present sample visual results of representative slices from the generated PET data
for qualitative comparison. Fig. 7.6, Fig. 7.7, and Fig. 7.8 shows the synthesized PET im-
ages from CN, MCI, and AD patients respectively. From the results, we could see that the
synthesized brain PET images are quite similar to the real brain PET images. To analyze
the similarity between synthetic and real images, we also obtained the 2D-histogram of real
and synthetic images. Fig. 7.9 presents the 2D-histogram of a sample real and synthetic
image.
There are several limitations to the proposed work. One possible extension could be
an increase from 2-D to 3-D input volumes, using 3-D GAN, at the cost of a longer pro-
cessing time and an increased memory usage. We trained separate GANs for each stage of
Alzheimer’s Disease, which increased the training complexity. Future research can focus on
the investigation of GAN architectures that generate multi-class samples together.
72
7.4 Summary
We conclude that synthetic medical image generation is a promising research area and
cost-saving approach for developing automated diagnostic technology. Our proposed model
can be generalized in other disease diagnosis systems using PET images and can help to
supplement the training dataset. The qualitative and quantitative evaluation of the proposed
model demonstrates that the synthesised images are close to real brain PET images of
different stages of Alzheimer’s Disease. We believe that our proposed model can help to
generate labelled images and aid data augmentation for developing robust disease diagnosis
systems, and eventually save lives.
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Chapter 8
UNDERSTANDING BEHAVIOR OF 3D CONVOLUTIONAL NEURAL
NETWORK FOR ALZHEIMER’S DISEASE AND MILD COGNITIVE
IMPAIRMENT DIAGNOSIS USING PET DATA
8.1 Introduction
In recent days, Convolutional Neural Networks (CNN) have demonstrated impressive
performance in medical image analysis. However, there is a lack of clear understanding of
why and how the Convolutional Neural Network performs so well for image analysis task.
How CNN analyzes an image and discriminates among samples of different classes are usu-
ally considered as non-transparent. As a result, it becomes difficult to apply CNN based
approaches in clinical procedure and automated disease diagnosis system. In this paper,
we consider this issue and work on visualizing and understanding the decision of Convolu-
tional Neural Network for Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI)
Diagnosis. We develop a 3D deep convolutional neural network for AD and MCI diagnosis
using brain PET scans and propose using five visualizations techniques - Sensitivity Analysis
(Backpropagation), Guided Backpropagation, Occlusion, Brain Area Occlusion, and Layer-
wise Relevance Propagation (LRP) to understand the decision of the CNN by highlighting
the relevant areas in the PET data. We conduct experiments using Alzheimer’s Disease
Neuroimaging Initiative (ADNI) dataset to train the model and evaluate the visualization
techniques.
Alzheimer’s Disease (AD) is a progressive neurodegenerative disease that causes people
to lose their memory, mental functions and ability to continue daily activities. AD is the
most prevailing type of dementia [119]. It is crucial to detect patient at earlier stage before
the disease progress further as there is no cure for AD. Currently, available treatment options
for Alzheimer’s Disease focus on slowing the progression of the disease and controlling symp-
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toms. So, earlier diagnosis can help for proper treatment and prevent brain tissue damage.
Alzheimer’s Disease is primarily caused by abnormal cell death, mainly in the medial
temporal lobe. Such cell death due to the accumulation of the β-amyloid peptide (Aβ)
within the brain and the neurofibrillary tangles of hyperphosphorylated tau protein are used
to identify Alzheimer’s Disease [128]. These amyloid deposits are caused by the deposition of
Aβ, a cleavage product of the amyloid precursor protein. The β-amyloid peptide (Aβ) orig-
inates from the degenerating mitochondria in dystrophic neurons. Such deposition causes
disruption of axons and additional deposition of amyloid [129]. Another important patho-
physiological step in the development of Alzheimer’s Disease is the Neurofibrillary tangles
caused by the hyperphosphorylation of tau protein [130].
(a) (b) (c)
Figure (8.1) Example of Brain PET Images (a) Normal Control (b) Mild Cognititve Impair-
ment (c) Alzheimer’s Disease.
Positron Emission Tomography is a class of nuclear medicine imaging. It is also known
as PET imaging or a PET scan. Nuclear medicine refers to a type of medical imaging meth-
ods that utilizes radioactive material in a small amount to diagnose and determine the stage
of a disease or treat a disease. Positron Emission Tomography (PET) uses small amounts of
radiotracers, a special camera and a computer to evaluate the physiological changes. Positron
Emission Tomography (PET) measures the body changes at the cellular level by looking at
blood flow, metabolism, neurotransmitters, and radiolabelled drugs. PET may identify early
onset of disease before it is evident on other imaging tests. It performs quantitative analyses
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Figure (8.2) Skull-Stripped PET Slices.
and finds relative changes over time as the disease process evolves or in response to a specific
stimulus [3].
PET imaging tracers can correlate β-amyloid deposition in the brain. The amyloid
deposition in the brain can be detected years before the onset of clinical signs of Alzheimer’s
Disease. The PET imaging tracers can help in differentiating dementia syndromes at the
early stage. PET scans reflect the resting state cerebral metabolic rates of glucose that is an
indicator of neuronal activity. Cerebral glucose metabolic alterations have distinct patterns
that can be used to identify Alzheimer’s Disease symptoms. Fig. 8.1 shows some brain PET
images with different AD stages.
Deep Convolutional Neural Networks have demonstrated immense achievements for im-
age analysis task in recent years, but understanding how they work yet remains a significant
challenge. The decision of the Convolutional Neural Networks for image analysis is often
considered non-transparent. So it is challenging to build trust for utilizing CNN in devel-
oping automated disease diagnosis system. It is essential to diagnose the disease as well
as explain the reason for the diagnosis to develop a trustworthy clinical decision support
system. To address this issue, understanding the behavior of CNN for classifying medical
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images for disease diagnosis is crucial.
Computer Vision community have utilized different visualization methods to understand
how Convolutional Neural Network works. Visualizing the learned features of the neurons in
different layers of the network is a standard way to understand CNN behavior. A heatmap is
generated and projected in the input image highlighting regions that influence the CNN for
the classification decision. But there is a lack of such work for medical image analysis using
convolutional neural networks. To mitigate this gap, we focus to utilize several visualiza-
tion methods to understand and explain the behavior of a convolutional neural network for
Alzheimer’s Disease and and Mild Cognitive Impairment diagnosis using brain PET data.
Figure (8.3) Alzheimer’s Disease diagnosis framework using PET data.
8.2 Method
8.2.1 Data Selection
For our proposed model, we have used 1230 PET scans (169 AD, 661 MCI, 400 CN) of
988 patients. We collected the data from the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) database (adni.loni.usc.edu). Specifically We used ADNI2 dataset for our model.
The subjects were in the age range 55-92. The ADNI was launched in 2003 as a public-
private partnership, led by Principal Investigator Michael W. Weiner, MD. The primary
goal of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron
emission tomography (PET), other biological markers, and clinical and neuropsychological
assessment can be combined to measure the progression of mild cognitive impairment (MCI)
and early Alzheimer’s disease (AD). Up-to-date information related ADNI database can be
found at www.adni-info.org.
77
Figure (8.4) 3D CNN Classifier for Alzheimer’s Disease and Mild Cognitive Impairment
diagnosis using PET data.
8.2.2 Data Preprocessing
PET Florbetapir (formerly AV-45)1 PET and FDG PET imaging were performed on the
patients by ADNI on two separate days (minimum 12hr time lapse). The PET Scans were
completed within two weeks before or two weeks after the in-clinic assessments at Baseline
and 24 months after Baseline. ADNI 2 subjects had up to 3 florbetapir scans and up to 2
FDG scans, each acquired at 2-year time intervals. We downloaded the raw Neuroimaging
Informatics Technology Initiative (NiFTI) file format PET scans from the ADNI website
(http://adni.loni.usc.edu/). To ensure the relative alignment among the subjects, we non-
linearly registered the PET scans to the 1mm resolution 2009c version of the ICBM152
reference brain using Advanced Normalization Tools (ANTs3). Since the raw scans are
not skull-stripped and have unnecessary information, skull stripping and normalization was
performed on them. Skull stripping includes removal of non-cerebral tissues like skull, scalp,
and dura from brain images and helps reduce computational complexity and time. After
this step, all the PET scans resulted in volumes of 193 * 229 * 193. Some slices from the
skull-stripped PET scan are shown in Fig. 8.2.
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Figure (8.5) Relevance Heatmaps for Sensitivity Analysis (Backpropagation) Method Aver-
aged Over CN Patients.
8.2.3 CNN Architecture
Let x = {xi, i = 1, ..., N}, a set of brain PET data with xi ∈ [0, 1, 2, ..., L − 1]h∗w∗l , a
three Dimensional (3D) image with L gray scale values, h*w*l voxels and y ∈ {0, 1, 2}, one
of the stages of AD where 0, 1, and 2 refers to normal/healthy control (CN), Mild Cognitive
Impairment (MCI) and Alzheimer’s Disease (AD) respectively. We constructed a classifier,
f : X → Y ; x 7→ y (8.1)
that predicts a label y in response to an input image x with minimum error rate. The
training process of the classifier is an iterative process to find the set of parameters w, that
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minimizes the classifier’s loss
L(w,X) =
1
n
n∑
i=1
l(f(xi, w), ĉi) (8.2)
where xi is i
th image of X, f(xi, w) is the classifier function that predicts the class ci of xi
given w, ĉi is the ground-truth class for i
th image xi and l(ci, ĉi) is the penalty function for
predicting ci instead of ĉi . We set l to the loss of cross–entropy,
l = −
∑
i
ĉi log ci (8.3)
Fig. 8.3 represents the block diagram of the Alzheimer’s Disease diagnosis model using
PET data. We developed a 3D Convolutional Neural Network inspired by the architecture
[131]. The CNN architecture is depicted in Fig. 8.4. The CNN classifier has several layers
performing the convolution, batch normalization, rectified linear unit, and pooling operation.
There are four convolutional layers and three fully connected layers. Final classification is
performed by the softmax layer with three different output classes: CN, MCI, and AD. We
optimized the CNN classifier using the Adam algorithm [114]. Though the focus of current
work is CNN visualization and not the classification performance, the model achieves a
classification performance of 88.76%.
8.2.4 Visualization Methods
Sensitivity Analysis (Backpropagation) Simonyan et al. [95] proposed an Image-
Specific Class Saliency Visualisation method that ranks the influence of an image, x, accord-
ing to its impact on a specific class score. The approach finds the relationship between an
output class score and the input x as the prediction of a specific class, y. Given an image I0,
a class c, and a classification ConvNet with the class score function Sc(I), the pixels of I0
are ranked based on their influence on the score Sc(I0). For CNN, the class score Sc(I) is a
highly non-linear function of I. The highly non-linear function of y = Sc(I) is approximated
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to be:
Sc(I) ≈ wT I + b (8.4)
where b is the bias of the model and w is the derivative of Sc with respect to the image I at
the point (image) I0:
w =
δSc
δI
|I0 (8.5)
Figure (8.6) Relevance Heatmaps for Sensitivity Analysis (Backpropagation) Method Aver-
aged Over MCI Patients.
Guided Backpropagation (GB) Guided backpropagation is a slightly modified ver-
sion of saliency extraction method proposed by Simonyan et al. [95]. Springenberg et al.
[96] proposed Guided backpropagation (GB) algorithm where the heatmap is generated using
the absolute values of the gradient of the output concerning the input nodes. The negative
gradients are set to zero at the rectification layers of the network to focus on what image
features the neuron detects. The GB method updates the gradient δ, the derivative with
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respect to the input (or activations for gradients of the intermediate layers) x, of ReLUs
during the backpropagation. A ReLU unit, y = max(0, x) backpropagates the gradient of
the layer next to the ReLU. The positive portion of the input δi−1 = δi, is backpropagated
where x > 0, δi > 0, δi is the gradient of the layer succeding the ReLU, and δi−1 is the
gradient after back propagating through ReLU.
Occlusion Sensitivity Zeiler et al. [94] proposed an Occlusion Sensitivity method to
understand the function of intermediate feature layers and the operation of a CNN classifier.
To interpret the feature activity in the intermediate layers of a CNN, they proposed to map
these activities back to the input pixel space. Thus they identified the input pattern that
initially caused a given activation in the feature maps. They also systematically occluded
different portions of the input image with a grey square and monitored the output of the
classifier. If the probability for the target class decreased compared to the original image,
this image region is considered to be relevant for that target class. To generate a relevance
heatmap, the patch is moved across the image, and the difference is calculated between
unoccluded and occluded probability.
Brain Area Occlusion This approach is inspired by a segmentation-based visual-
ization approach proposed by Yang et al. [97]. We occlude an entire brain area based
on the Automated Anatomical Labeling atlas (AAL, http://www.gin.cnrs.fr/en/tools/aal-
aal2/) following [132] and calculate the difference between unoccluded and occluded proba-
bility.
Layer-wise Relevance Propagation (LRP) Bach et al. [99] proposed Layer-wise
Relevance Propagation (LRP) algorithm to understand the classification decisions of the
model by pixel-wise decomposition. They attempted to visualize the contributions of single
pixels to predictions for kernel-based classifiers over Bag of Words features and for multi-
layered neural networks. Heatmaps can be produced from the pixel visualization of LRP
method and provided to human expert for validation and analysis. The approach focuses on
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finding relevance to individual input nodes and trace back contributions to the final output
node in a layer by layer fashion. Each of the nodes in layer l, that contributes to the acti-
vation of a node j in layer l+ 1 has a part in the relevance Rjl+1. The total relevance or the
activation strength of an output node for a particular class is computed as:
∑
i
Ri→jl,l+1 = R
j
l+1 (8.6)
8.3 Experiments and Results
For our work, we used 80% data from the dataset as the training set, and 20% as test
dataset. From the training dataset, a random selection of 10% images is used as validation
dataset. The training-test and training-validation split were done at the subject/patient
level. The experiments were performed using PyTorch framework. The parameters used for
the training process are learning rate: 0.0001, weight decay: 0.1 after every seven epochs,
and batch size: 16.
8.3.1 Classification Result
The network achieves a comparable classification accuracy of 88.76% for CN/AD clas-
sification and 64.57% for CN/MCI classification. Please note that the focus of the current
study is CNN visualization and not classification performance. In our experiment, we also
developed a 2D-CNN model using axial, coronal, and sagittal slices from PET data that
achieved 71.45% classification accuracy for CN/AD classification. The vast difference in
the classification result suggests that 3D-CNN networks have better capability to learn fea-
tures from three-dimensional PET image data. Though to validate such findings, further
experiments are necessary.
8.3.2 Visualization
We generated relevance relevance heatmaps for all visualizations methods, averaged over
CN, MCI, and AD PET images in the test dataset. Fig. 8.5, Fig. 8.6, and Fig. 8.7 repre-
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Figure (8.7) Relevance Heatmaps for Sensitivity Analysis (Backpropagation) Method Aver-
aged Over AD Patients.
sents the relevance heatmaps generated for Sensitivity Analysis (Backpropagation) Method
for CN, MCI, and AD patients respectively. Fig. 8.8, Fig. 8.9, and Fig. 8.10 represents the
relevance heatmaps generated for Guided Backpropagation Method for CN, MCI, and AD
patients respectively. Fig. 8.11, Fig. 8.12, and Fig. 8.13 represents the relevance heatmaps
generated for Occlusion Method for CN, MCI, and AD patients respectively. Fig. 8.14,
Fig. 8.15, and Fig. 8.16 represents the relevance heatmaps generated for Brain Area Occlu-
sion Method for CN, MCI, and AD patients respectively. Fig. 8.17, Fig. 8.18, and Fig. 8.19
represents the relevance heatmaps generated for LRP Method for CN, MCI, and AD patients
respectively. Fig. 8.20 presents the visual comparison of these five methods. The red ar-
eas/dots indicate that regions were important for the decision making of the 3D-CNN model.
From the result, we can see that all the visualization focuses mostly on similar brain
regions and the generated heatmaps for CN, MCI, and MCI patients are similar. It indicates
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that the network focuses on the same regions to identify the stage of Alzheimer’s Disease.
There are some differences, such as the heatmaps generated for the gradient-based methods
are distributed. The heatmaps highlight the areas that the CNN network is most susceptible.
For the LRP method, the heatmap shows the average relevance of each voxel for contributing
to the Alzheimer’s Disease diagnosis score. The heatmaps generated by the occlusion based
methods are more focused on the specific regions and cannot administer with large areas of
distributed relevance. The reason behind the issue is the occlusion path were not able to
cover those areas (for example, the cortex) completely. Brain area occlusion presents very
high relevance for the temporal lobe. Since in this method, only one area is covered at a
time, that can cause such high importance for one region and minimal relevance for other
areas.
Figure (8.8) Relevance Heatmaps for Guided Backpropagation Method Averaged Over CN
Patients.
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Figure (8.9) Relevance Heatmaps for Guided Backpropagation Method Averaged Over MCI
Patients.
8.3.3 Impact of Brain Region
To evaluate the visualization result, we consider the literature available from the medical
domain [133], [134], as there is no ground truth for validating the generated heatmaps. The
top five most relevant regions for each visualization method is shown in Table. 8.1. The
relevance in each area following the AAL atlas was summed together to identify the most
relevant regions for CN, MCI, and AD PET scans. From the top five relevant brain area for
each visualization method, we can see that the 3D-CNN focuses on the temporal lobe area,
including hippocampus for CN/MCI/AD classification. So, our findings are similar to those
in medical literature [133], [134].
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Figure (8.10) Relevance Heatmaps for Guided Backpropagation Method Averaged Over AD
Patients.
8.4 Summary
We developed a 3D Convolutional Neural Network for Alzheimer’s Disease and Mild
Cognitive Impairment classification and applied five visualization methods to understand
the network’s behavior to classify sample brain PET data. The 3D-CNN focuses on the
temporal lobe area, including hippocampus for CN/MCI/AD classification. Our findings are
similar to those in medical literature, and these biomarkers were identified directly from the
network’s decision without having any ground truth. Such findings are crucial for building
trust in clinical practitioners for adapting automated disease diagnosis systems. Our pro-
posed approach can be extended for understanding CNN behavior for other disease diagnosis
systems too. In future, we plan to analyze the generated heatmaps for the misclassified sam-
ples and identify the regions and patterns that can cause false positive and false negative
results.
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Figure (8.11) Relevance Heatmaps for Occlusion Method Averaged Over CN Patients.
Figure (8.12) Relevance Heatmaps for Occlusion Method Averaged Over MCI Patients.
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Figure (8.13) Relevance Heatmaps for Occlusion Method Averaged Over AD Patients.
Table (8.1) Brain Area Relevance for CN, MCI, and AD Patient for Each Visualization
Method
Sensitivity
Analysis
(Backpropagation)
Guided
Backpropagation
Occlusion
Sensitivity
Brain Area
Occlusion
Layer-wise Relevance
Propagation (LRP)
CN
Frontal Mid (5.78%)
Precuneus (5.01%)
Postcentral (4.75%)
Temporal Mid (4.49%)
Precentral (4.05%)
Frontal Mid (6.31%)
Precuneus (4.87%)
Postcentral (4.70%)
Precentral (4.23%)
Temporal Mid (3.74%)
Precuneus (7.96%)
Postcentral (7.09%)
Precentral (5.11%)
Temporal Mid (5.03%)
Parietal Sup (4.39%)
Precuneus 14.96%)
Temporal Mid (9.14%)
Postcentral (7.11%)
Temporal Inf (5.62%)
Frontal Mid (5.25%)
Cerebral White Matter (21.7%)
Cerebellum (11.74%)
Frontal Mid (5.83%)
Precuneus (3.72%)
Frontal Sup R (3.52%)
MCI
Frontal Mid (5.23%)
Temporal Mid (4.61%)
Postcentral (4.40%)
Precuneus (4.37%)
Occipital Mid (3.92%)
Frontal Mid (5.61%)
Occipital Mid (4.60%)
Precuneus (4.48%)
Postcentral (4.36%)
Temporal Mid (4.13%)
Postcentral (7.69%)
Temporal Mid (6.75%)
Parietal Inf (5.91%)
Precuneus (5.41%)
Precentral (4.66%)
Temporal Mid (15.94%)
Postcentral (7.89%)
Occipital Mid (7.89%))
Precuneus (7.53%)
Precentral (5.97%)
Cerebral White Matter (42.69%)
Cerebellum (7.87%)
Frontal Mid (3.43%)
Angular Gyr. (3.10%)
Lateral Ventricles (2.99%)
AD
Frontal Mid (5.59%)
Precuneus (4.87%)
Postcentral (4.82%)
Temporal Mid (4.57%)
Precentral (4.32%)
Frontal Mid (5.92%)
Postcentral (4.72%)
Precuneus (4.55%)
Precentral (4.34%)
Temporal Inf (3.90%)
Postcentral (8.77%)
Precuneus (8.14%)
Precentral (5.05%)
Parietal Sup (5.01%)
Temporal Mid (4.82%)
Precuneus (14.11%)
Temporal Mid (13.27%)
Temporal Inf (9.51%)
Frontal Mid (5.51%)
Angular (4.79%)
Cerebral White Matter (32.60%)
Cerebellum (9.78%)
Frontal Mid (3.26%)
Lateral Ventricles (3.02%)
Brain Stem (2.93%)
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Figure (8.14) Relevance Heatmaps for Brain Area Occlusion Method Averaged Over CN
Patients.
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Figure (8.15) Relevance Heatmaps for Brain Area Occlusion Method Averaged Over MCI
Patients.
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Figure (8.16) Relevance Heatmaps for Brain Area Occlusion Method Averaged Over AD
Patients.
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Figure (8.17) Relevance Heatmaps for Layer-wise Relevance Propagation (LRP) Method
Averaged Over CN Patients.
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Figure (8.18) Relevance Heatmaps for Layer-wise Relevance Propagation (LRP) Method
Averaged Over MCI Patients.
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Figure (8.19) Relevance Heatmaps for Layer-wise Relevance Propagation (LRP) Method
Averaged Over AD Patients.
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(a) (b)
(c) (d)
(e)
Figure (8.20) Visualization Comparison of the Relevance Heatmaps. (a) Sensitivity Analysis
( Backpropagation). (b) Guided Backpropagation. (c) Occlusion. (d) Brain Area Occlusion.
(e) Layer-wise Relevance Propagation (LRP).
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Chapter 9
FUTURE WORK
In this section, we are presenting more future problems, challenges, and pointing out
the future research directions.
9.1 RESEARCH DIRECTIONS
In this dissertation, we have addressed several challenges related to medical image anal-
ysis with deep learning technologies for developing better disease diagnosis model. Most of
our work used 2D-CNN utilizing slices from the axial, coronal, sagittal view of 3D MRI data.
While working for CNN visualization, we developed two 3D-CNN models for MRI and PET
data analysis, and they showed promises for better diagnosis result. In future, we plan to
utilize the 3D-CNN model for analyzing medical images for other neurological disorders.
Developing a multimodal system for diagnosing disease using data from different modal-
ities, such as PET and MRI, could improve the diagnosis process. In future, we plan to de-
velop such systems that can utilize data from different modalities and offer better diagnosis
result.
We have generated synthetic data for different stages of Alzheimer’s disease using Gen-
erative Adversarial networks. Such data will help a lot to increase the volume of the training
set for training a model to identify the progression of the disease. Another exciting research
direction would be generating data samples from one modality to another, such as - MRI to
PET or vice versa. For synthetic medical data generation, one possible extension could be an
increase from 2D to 3D input volumes, using 3D GAN. We trained separate GANs for each
stage of Alzheimer’s Disease, which increased the training complexity. Future research can
focus on the investigation of GAN architectures that generate multi-class samples together.
Additionally, we plan to apply our model for generating synthetic data for other diseases,
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especially neurological disorders.
In this dissertation, we have generated heatmaps for understanding CNN behavior for
Alzheimer’s Disease Diagnosis. Generating ground truth for such relevance heatmaps to
identify Alzheimer’s Disease progression could be another exciting research direction. Fur-
thermore, to analyze the generated heatmaps for the misclassified samples and identify the
regions and patterns that can cause false positive and false negative results can help devel-
oping better disease diagnosis model.
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Chapter 10
CONCLUSIONS
This dissertation has presented our examination of learning deep feature representations
for medical image analysis to develop better disease diagnosis system. We have presented
approaches for diagnosis of Alzheimer’s disease from brain MRI and PET data and presented
strong results showing the effectiveness of these methods.
First, we made an efficient approach to AD diagnosis using brain MRI data analysis.
Our proposed network can be very beneficial for early-stage Alzheimer’s Disease diagnosis.
Though the proposed model has been tested only on Alzheimer’s Disease dataset, we believe
it can be used successfully for other classification problems of medical domain. Moreover,
the proposed approach has strong potential to be used for applying CNN into other areas
with a limited dataset.
Second, we demonstrated ways to improve the performance of a CNN classifier. The
experimental result shows that a pre-trained network with preprocessed slices from coronal
view is a reliable technique for MCI and AD diagnosis. The performance of the proposed
model shows that it can compete with other state-of-the-art methods for AD diagnosis using
3D brain MRI data.
Third, we proposed approaches for synthetic medical image generation to solve the
limited dataset problem for developing automated diagnosis model. Our proposed model
can be generalized in other disease diagnosis systems using PET images and can help to
supplement the training dataset. The qualitative and quantitative evaluation of the proposed
model demonstrates that the synthesised images are close to real brain PET images of
different stages of Alzheimer’s Disease. We believe that our proposed model can help to
generate labelled images and aid data augmentation for developing robust disease diagnosis
systems.
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Fourth, we developed a 3D Convolutional Neural Network for Alzheimer’s Disease and
Mild Cognitive Impairment classification and applied five visualization methods to under-
stand the network’s behavior to classify sample brain PET data. The 3D-CNN focuses on
the temporal lobe area, including hippocampus for CN/MCI/AD classification. Our find-
ings are similar to those in medical literature, and these biomarkers were identified directly
from the network’s decision without having any ground truth. Such findings are crucial
for building trust in clinical practitioners for adapting automated disease diagnosis systems.
Our proposed approach can be extended for understanding CNN behavior for other disease
diagnosis systems too.
To conclude, this dissertation proposed approaches that have the potential to improve
the development of automated disease diagnosis system, especially Alzheimer’s Disease and
Mild Cognitive Impairment. We believe our methods can be utilized for medical image
analysis of other diseases to perform accurate and early diagnosis, and eventually save lives.
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